The Clorox Company (CLX) 8-K 4 Dec 14 2014 FY Other Events Financial data

DOCUMENT_AND_ENTITY_INFORMATIO

DOCUMENT AND ENTITY INFORMATION (USD $)	12 Months Ended
In Billions, except Share data, unless otherwise specified	Jun. 30, 2014	Jul. 31, 2014	Dec. 31, 2013
Document and Entity Information [Abstract]	'	'	'
Document Type	'8-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	30-Jun-14	'	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'FY	'	'
Entity Registrant Name	'CLOROX CO /DE/	'	'
Entity Central Index Key	'0000021076	'	'
Current Fiscal Year End Date	'--06-30	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Common Stock, Shares Outstanding	'	128,845,437	'
Entity Public Float	'	'	$11.90

CONSOLIDATED_STATEMENTS_OF_EAR

CONSOLIDATED STATEMENTS OF EARNINGS (USD $)	12 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
CONSOLIDATED STATEMENTS OF EARNINGS [Abstract]	'	'	'
Net sales	$5,514	$5,533	$5,379
Cost of products sold	3,158	3,142	3,107
Gross profit	2,356	2,391	2,272
Selling and administrative expenses	751	793	783
Advertising costs	503	498	477
Research and development costs	125	130	121
Interest expense	103	122	125
Other income, net	-10	-4	-12
Earnings from continuing operations before income taxes	884	852	778
Income taxes on continuing operations	305	279	243
Earnings from continuing operations	579	573	535
(Losses) earnings from discontinued operations, net of tax	-21	-1	6
Net earnings	$558	$572	$541
Net earnings (losses) per share, basic	'	'	'
Continuing operations	$4.47	$4.37	$4.09
Discontinued operations	($0.16)	$0	$0.05
Basic net earnings per share	$4.31	$4.37	$4.14
Net earnings (losses) per share, diluted	'	'	'
Continuing operations	$4.39	$4.31	$4.05
Discontinued operations	($0.16)	($0.01)	$0.04
Diluted net earnings per share	$4.23	$4.30	$4.09
Weighted average shares outstanding (in thousands)	'	'	'
Basic	129,558	131,075	130,852
Diluted	131,742	132,969	132,310

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME [Abstract]	'	'	'
Earnings from continuing operations	$579	$573	$535
(Losses) earnings from discontinued operations, net of tax	-21	-1	6
Net earnings	558	572	541
Other comprehensive (losses) income:	'	'	'
Foreign currency translation adjustments, net of tax	-37	-11	-41
Net unrealized (losses) gains on derivatives, net of tax	-9	3	-37
Pension and postretirement benefit adjustments, net of tax	-4	37	-68
Total other comprehensive (losses) income, net of tax	-50	29	-146
Comprehensive income	$508	$601	$395

CONSOLIDATED_STATEMENTS_OF_COM1

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME [Abstract]	'	'	'
Tax on foreign currency translation adjustments	$11	($5)	($1)
Tax on net unrealized (losses) gains on derivatives	-6	1	-4
Tax on pension and postretirement benefit adjustments	$4	($22)	$37

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified
Current assets	'	'
Cash and cash equivalents	$329	$299
Receivables, net	546	580
Inventories, net	386	394
Other current assets	134	147
Total current assets	1,395	1,420
Property, plant and equipment, net	977	1,021
Goodwill	1,101	1,105
Trademarks, net	547	553
Other intangible assets, net	64	74
Other assets	174	138
Total assets	4,258	4,311
Current liabilities	'	'
Notes and loans payable	143	202
Current maturities of long-term debt	575	0
Accounts payable	440	413
Accrued liabilities	472	490
Income taxes payable	8	29
Total current liabilities	1,638	1,134
Long-term debt	1,595	2,170
Other liabilities	768	742
Deferred income taxes	103	119
Total liabilities	4,104	4,165
Commitments and contingencies	'	'
Stockholders' equity	'	'
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 158,741,461 shares issued at June 30, 2014 and 2013; and 128,796,228 and 130,366,911 shares outstanding at June 30, 2014 and 2013, respectively	159	159
Additional paid-in capital	709	661
Retained earnings	1,739	1,561
Treasury shares, at cost: 29,945,233 and 28,374,550 shares at June 30, 2014 and 2013, respectively	-2,036	-1,868
Accumulated other comprehensive net loss	-417	-367
Stockholders' equity	154	146
Total liabilities and stockholders' equity	$4,258	$4,311

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Jun. 30, 2014	Jun. 30, 2013
CONSOLIDATED BALANCE SHEETS [Abstract]	'	'
Preferred stock, par value	$1	$1
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$1	$1
Common stock, shares authorized	750,000,000	750,000,000
Common stock, shares issued	158,741,461	158,741,461
Common stock, shares outstanding	128,796,228	130,366,911
Treasury stock, shares	29,945,233	28,374,550

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Shares [Member]	Accumulated Other Comprehensive Net (Losses) Income [Member]	Total
In Millions, except Share data in Thousands
Balance, amount at Jun. 30, 2011	$159	$632	$1,143	($1,770)	($250)	($86)
Balance, shares at Jun. 30, 2011	158,741	'	'	-27,675	'	'
Net earnings	'	'	541	'	'	541
Other comprehensive (losses) income	'	'	'	'	-146	-146
Accrued dividends	'	'	-320	'	'	-320
Stock-based compensation	'	27	'	'	'	27
Other employee stock plan activities, amount	'	-26	-14	114	'	74
Other employee stock plan activities, shares	'	'	'	1,915	'	'
Treasury stock purchased, amount	'	'	'	-225	'	-225
Treasury stock purchased, shares	'	'	'	-3,419	'	'
Balance, amount at Jun. 30, 2012	159	633	1,350	-1,881	-396	-135
Balance, shares at Jun. 30, 2012	158,741	'	'	-29,179	'	'
Net earnings	'	'	572	'	'	572
Other comprehensive (losses) income	'	'	'	'	29	29
Accrued dividends	'	'	-348	'	'	-348
Stock-based compensation	'	35	'	'	'	35
Other employee stock plan activities, amount	'	-7	-13	141	'	121
Other employee stock plan activities, shares	'	'	'	2,304	'	'
Treasury stock purchased, amount	'	'	'	-128	'	-128
Treasury stock purchased, shares	'	'	'	-1,500	'	'
Balance, amount at Jun. 30, 2013	159	661	1,561	-1,868	-367	146
Balance, shares at Jun. 30, 2013	158,741	'	'	-28,375	'	'
Net earnings	'	'	558	'	'	558
Other comprehensive (losses) income	'	'	'	'	-50	-50
Accrued dividends	'	'	-374	'	'	-374
Stock-based compensation	'	36	'	'	'	36
Other employee stock plan activities, amount	'	12	-6	92	'	98
Other employee stock plan activities, shares	'	'	'	1,476	'	'
Treasury stock purchased, amount	'	'	'	-260	'	-260
Treasury stock purchased, shares	'	'	'	-3,046	'	'
Balance, amount at Jun. 30, 2014	$159	$709	$1,739	($2,036)	($417)	$154
Balance, shares at Jun. 30, 2014	158,741	'	'	-29,945	'	'

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Operating activities:	'	'	'
Net earnings	$558	$572	$541
Deduct: (Losses) earnings from discontinued operations, net of tax	-21	-1	6
Earnings from continuing operations	579	573	535
Adjustments to reconcile earnings from continuing operations to net cash provided by continuing operations:	'	'	'
Depreciation and amortization	177	180	177
Stock-based compensation	36	35	27
Deferred income taxes	-21	-8	-11
Funding of non-qualified deferred compensation plans	-26	0	0
Other	32	20	-36
Changes in:	'	'	'
Receivables, net	20	-10	-50
Inventories, net	1	-11	6
Other current assets	5	12	-2
Accounts payable and accrued liabilities	-12	-29	11
Income taxes payable	-5	18	-35
Net cash provided by continuing operations	786	780	622
Net cash used for discontinued operations	-19	-5	-10
Net cash provided by operations	767	775	612
Investing activities:	'	'	'
Capital expenditures	-137	-190	-189
Proceeds from sale-leasebacks, net of transaction costs	0	135	0
Businesses acquired, net of cash acquired	0	0	-93
Other	0	4	8
Net cash used for investing activities from continuing operations	-137	-51	-274
Net cash used for investing activities by discontinued operations	-1	-4	-3
Net cash used for investing activities	-138	-55	-277
Financing activities:	'	'	'
Notes and loans payable, net	-60	-98	-164
Long-term debt borrowings, net of issuance costs	0	593	297
Long-term debt repayments	0	-850	0
Treasury stock purchased	-260	-128	-225
Cash dividends paid	-368	-335	-315
Issuance of common stock for employee stock plans and other	96	133	86
Net cash used for financing activities	-592	-685	-321
Effect of exchange rate changes on cash and cash equivalents	-7	-3	-6
Net increase in cash and cash equivalents	30	32	8
Cash and cash equivalents:	'	'	'
Beginning of year	299	267	259
End of year	329	299	267
Supplemental cash flow information:	'	'	'
Interest paid	76	129	123
Income taxes paid, net of refunds	312	263	292
Noncash financing activities:	'	'	'
Cash dividends declared and accrued, but not paid	$95	$93	$85

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Jun. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUTING POLICIES [Abstract]	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Nature of Operations and Basis of Presentation
	The Company is principally engaged in the production, marketing and sales of consumer products through mass retail outlets, e-commerce channels, distributors and medical supply providers. The consolidated financial statements include the statements of the Company and its wholly owned and controlled subsidiaries. All significant intercompany transactions and accounts were eliminated in consolidation. Certain prior year reclassifications were made in the consolidated financial statements and related notes to the consolidated financial statements to conform to the current year presentation.
	As discussed more fully under Note 2 – Discontinued Operations, the Company's Venezuela affiliate, Corporación Clorox de Venezuela S.A. (Clorox Venezuela), a component of the International reportable segment, discontinued its operations effective September 22, 2014. Since this exit occurred subsequent to the filing of the Company's Annual Report on Form 10-K for the year ended June 30, 2014, the Company has reclassified the financial results of Clorox Venezuela as a discontinued operation in the consolidated financial statements for all periods presented herein.
	Use of Estimates
	The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect reported amounts and related disclosures. Specific areas requiring the application of management's estimates and judgments include assumptions pertaining to accruals for consumer and trade-promotion programs, stock-based compensation costs, pension and post-employment benefit costs, future cash flows associated with impairment testing of goodwill and other long-lived assets, the credit worthiness of customers, uncertain tax positions, tax valuation allowances and legal, environmental and insurance matters. Actual results could materially differ from estimates and assumptions made.
	Recently Issued Accounting Pronouncements
	In May 2014, the Financial Accounting Standards Board (FASB) issued an update to current accounting standards, which establishes a single, comprehensive revenue recognition model for all contracts with customers, and will supersede most current revenue recognition guidance. It requires entities to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments are effective for the Company beginning in the first quarter of fiscal year 2018. Early adoption is not permitted. The Company is currently in the process of evaluating the impact of the adoption of these requirements on its consolidated financial statements.
	In April 2014, the FASB issued an update to current accounting standards, which will change the criteria for reporting discontinued operations. The amendments will also require new disclosures about discontinued operations and disposals of components of an entity that do not qualify for discontinued operations reporting. The amendments are effective for the Company for new disposals (or classifications as held for sale) of components of the Company, should they occur, beginning in the first quarter of fiscal year 2016. Early adoption is permitted for disposals (or classifications as held for sale) that have not been previously reported. The Company does not expect the adoption of the new standard to materially impact its reporting of Clorox Venezuela.
	Cash and Cash Equivalents
	Cash equivalents consist of highly liquid instruments, time deposits and money market funds with an initial maturity at purchase of three months or less. The fair value of cash and cash equivalents approximates the carrying amount.
	The Company's cash position includes amounts held by foreign subsidiaries and, as a result, the repatriation of certain cash balances from some of the Company's foreign subsidiaries could result in additional tax costs. However, these cash balances are generally available without legal restriction to fund local business operations. In addition, a portion of the Company's cash balance is held in U.S. dollars by foreign subsidiaries, whose functional currency is their local currency. Such U.S. dollar balances are reported on the foreign subsidiaries' books, in their functional currency, with the impact from foreign currency exchange rate differences recorded in other income, net. The Company's cash holdings were as follows as of June 30:
			2014		2013
	U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent		$	180	$	130
	Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries			132		115
	U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries			12		36
	Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries			5		18
	Total		$	329	$	299
	Inventories
	Inventories are stated at the lower of cost or market. When necessary, the Company provides allowances to adjust the carrying value of its inventory to the lower of cost or market, including any costs to sell or dispose. Appropriate consideration is given to obsolescence, excessive inventory levels, product deterioration and other factors in evaluating net realizable value for the purposes of determining the lower of cost or market.
	Property, Plant and Equipment and Finite-Lived Intangible Assets
	Property, plant and equipment and finite-lived intangible assets are stated at cost. Depreciation and amortization expense are calculated by the straight-line method using the estimated useful lives or lives determined by lease contracts of the related assets. The table below provides estimated useful lives of property, plant and equipment by asset classification.
		Estimated
		Useful Lives
	Buildings and leasehold improvements	10 - 40 years
	Land improvements	10 - 30 years
	Machinery and equipment	3 - 15 years
	Computer equipment	3 - 5 years
	Capitalized software costs	3 - 7 years
	Property, plant and equipment and finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset (or asset group) may not be fully recoverable. The risk of impairment is initially assessed based on an estimate of the undiscounted cash flows at the lowest level for which identifiable cash flows exist. Impairment occurs when the book value of the asset exceeds the estimated future undiscounted cash flows generated by the asset and the impairment is viewed as other than temporary. When an impairment is indicated, an impairment charge is recorded for the difference between the book value of the asset and its estimated fair market value. Depending on the asset, estimated fair market value may be determined either by use of a discounted cash flow model or by reference to estimated selling values of assets in similar condition.
	Capitalization of Software Costs
	The Company capitalizes certain significant costs incurred in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest and payroll and payroll-related costs for employees during the application development stage. Costs incurred prior to the application development stage, costs incurred once the application is substantially complete and ready for its intended use and other costs not qualifying for capitalization, including training and maintenance costs, are charged to expense. Capitalized software amortization expense was $22, $21 and $18, in fiscal years 2014, 2013 and 2012, respectively.
	Impairment Review of Goodwill and Indefinite-Lived Intangible Assets
	The Company tests its goodwill, trademarks with indefinite lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications during a different interim period that these assets may have become impaired. With respect to goodwill, the Company performs either a qualitative or quantitative evaluation for each of its reporting units. Factors considered in the qualitative test include maturity and stability of the reporting unit, magnitude of excess fair value over book value from past year's impairment testing, other reporting unit specific operating results as well as new events and circumstances impacting the operations at the reporting unit level. If the result of a qualitative test indicates a potential for impairment of a reporting unit, a quantitative test is performed. The quantitative test is a two-step process. In the first step, the Company compares the estimated fair value of the reporting unit to its carrying value. If the estimated fair value of any reporting unit is less than its carrying value, the Company performs a second step to determine the implied fair value of the reporting unit's goodwill. If the carrying amount of a reporting unit's goodwill exceeds its implied fair value, an impairment charge is recorded for the difference between the carrying amount and the implied fair value of the reporting unit's goodwill. For trademarks and other intangible assets with indefinite lives, the Company performs a quantitative analysis to test for impairment and compares the estimated fair value of an asset to its carrying amount. If the carrying amount of such asset exceeds its estimated fair value, an impairment charge is recorded for the difference between the carrying amount and the estimated fair value. The Company's estimates of fair value are based primarily on a discounted cash flow or income approach that requires significant management judgment with respect to future sales volumes, revenue and expense growth rates, changes in working capital, foreign exchange rates, currency devaluation, inflation and a perpetuity growth rate.
	Stock-based Compensation
	The Company grants various nonqualified stock-based compensation awards to eligible employees, including stock options and performance units.
	For stock options, the Company estimates the fair value of each award on the date of grant using the Black-Scholes valuation model, which requires management to make estimates regarding expected option life, stock price volatility and other assumptions. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The Company estimates stock option forfeitures based on historical data for each employee grouping. The total number of stock options expected to vest is adjusted by actual and estimated forfeitures. Changes to the actual and estimated forfeitures will result in a cumulative catch-up adjustment in the period of change. Compensation expense is recorded by amortizing the grant date fair values on a straight-line basis over the vesting period, adjusted for estimated forfeitures.
	The Company's performance unit grants provide for the issuance of common stock to certain managerial staff and executive management if the Company achieves specified performance targets. The performance period is three years and the payout determination is made at the end of the three-year performance period. The fair value of each grant issued is estimated on the date of grant based on the current market price of the stock. The total amount of compensation expense recognized reflects estimated forfeiture rates and the initial assumption that performance goals will be achieved. Compensation expense is adjusted based on management's assessment of the probability that performance goals will be achieved. If such goals are not met or it is determined that achievement of performance goals is not probable, previously recognized compensation expense is trued up in the current period to reflect the expected payout level. If it is determined that the performance goals will be exceeded, additional compensation expense is recognized, subject to a cap of 150% of target.
	Cash flows resulting from tax deductions in excess of the cumulative compensation cost recognized for stock-based payment arrangements (excess tax benefits) are classified as financing cash inflows.
	Employee Benefits
	The Company accounts for its defined benefit retirement income and retirement health care plans using actuarial methods. These methods use an attribution approach that generally spreads “plan events” over the service lives or expected lifetime (for frozen plans) of plan participants. Examples of plan events are plan amendments and changes in actuarial assumptions such as the expected return on plan assets, discount rate, rate of compensation increase and certain employee-related factors, such as retirement age and mortality. The principle underlying the attribution approach is that employees render service over their employment period on a relatively “smooth” basis and, therefore, the statement of earnings effects of retirement income and retirement health care plans are recognized in the same pattern.
	One of the principal assumptions used in the net periodic benefit cost calculation is the expected return on plan assets. The required use of an expected return on plan assets may result in recognized pension expense or income that differs from the actual returns of those plan assets in any given year. Over time, however, the goal is for the expected long-term returns to approximate the actual returns and, therefore, the expectation is that the pattern of income and expense recognition should closely match the pattern of the services provided by the participants. The Company uses a market-related value method for calculating plan assets for purposes of determining the amortization of actuarial gains and losses. This method employs an asset smoothing approach. The differences between actual and expected returns are recognized in the net periodic benefit cost calculation over the average remaining service period or expected lifetime (for frozen plans) of the plan participants using the corridor approach. Under this approach, only actuarial gains (losses) that exceed 5% of the greater of the projected benefit obligation or the market-related value of assets are amortized to pension expense by the Company. In developing its expected return on plan assets, the Company considers the long-term actual returns relative to the mix of investments that comprise its plan assets and also develops estimates of future investment returns by considering external sources.
	The Company recognizes an actuarial-based obligation at the onset of disability for certain benefits provided to individuals after employment, but before retirement, that include medical, dental, vision, life and other benefits.
	Environmental Costs
	The Company is involved in certain environmental remediation and ongoing compliance activities. Accruals for environmental matters are recorded on a site-by-site basis when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. The Company's accruals reflect the anticipated participation of other potentially responsible parties in those instances where it is probable that such parties are legally responsible and financially capable of paying their respective shares of the relevant costs. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Actual costs to be incurred at identified sites in future periods may vary from the estimates, given the inherent uncertainties in evaluating environmental exposures. The aggregate accrual for environmental matters is included in other liabilities in the Company's consolidated balance sheets on an undiscounted basis due to uncertainty regarding the timing of future payments.
	Revenue Recognition
	Sales are recognized as revenue when the risk of loss and title pass to the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed or determinable and collection is reasonably assured. Sales are recorded net of allowances for returns, trade promotions, coupons and other discounts. The Company routinely commits to one-time or ongoing trade-promotion programs with customers and consumer coupon programs that require the Company to estimate and accrue the expected costs of such programs. Programs include shelf price reductions, end-of-aisle or in-store displays of the Company's products and graphics and other trade-promotion activities conducted by the customer. Coupons are recognized as a liability when distributed based upon expected consumer redemptions. The Company maintains liabilities related to these programs for the estimated expenses incurred, but not paid, at the end of each period. Trade-promotion and coupon redemption costs are recorded as a reduction of sales. The Company provides an allowance for doubtful accounts based on its historical experience and ongoing assessment of its customers' credit risk. Receivables were presented net of an allowance for doubtful accounts of $3 and $5 as of June 30, 2014 and 2013, respectively. The Company's provision for doubtful accounts was $0, $0 and $3 in fiscal years 2014, 2013 and 2012, respectively.
	Receivables, net, included non-customer receivables of $15 and $13 as of June 30, 2014 and 2013, respectively.
	Cost of Products Sold
	Cost of products sold represents the costs directly related to the manufacture and distribution of the Company's products and primarily includes raw materials, packaging, contract packer fees, shipping and handling, warehousing, package design, depreciation, amortization, direct and indirect labor and operating costs for the Company's manufacturing and distribution facilities including salary, benefit costs and incentive compensation, and royalties and amortization related to the Company's Glad Venture Agreement (see Note 11 – Other Liabilities).
	Costs associated with developing and designing new packaging are expensed as incurred and include design, artwork, films and labeling. Expenses for fiscal years ended June 30, 2014, 2013 and 2012 were $12, $10 and $10, respectively, all of which were reflected in cost of products sold or discontinued operations, as appropriate, in the consolidated statements of earnings.
	Selling and Administrative Expenses
	Selling and administrative expenses represent costs incurred by the Company in generating revenues and managing the business and include market research, commissions and certain administrative expenses. Administrative expenses include salary, benefits, incentive compensation, professional fees and services, software and licensing fees and other operating costs associated with the Company's non-manufacturing, non-research and development staff, facilities and equipment.
	Advertising and Research and Development Costs
	The Company expenses advertising and research and development costs in the period incurred.
	Income Taxes
	The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax bases. Management reviews the Company's deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company's tax provision in the period of change. In addition to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet certain recognition thresholds or measurement standards. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available or when positions are effectively settled.
	U.S. income tax expense and foreign withholding taxes are provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.
	Foreign Currency Transactions and Translation
	Local currencies are the functional currencies for substantially all of the Company's foreign operations. When the transactional currency is different than the functional currency, transaction gains and losses are included as a component of other income, net. In addition, certain assets and liabilities denominated in currencies different than a foreign subsidiary's functional currency are reported on the subsidiary's books in its functional currency, with the impact from exchange rate differences recorded in other income, net. Except for Clorox Venezuela as discussed below and in Note 2 – Discontinued Operations, assets and liabilities of foreign operations are translated into U.S. dollars using the exchange rates in effect at the balance sheet date, while income and expenses are translated at the average monthly exchange rates during the year.
	Gains and losses on foreign currency translations are reported as a component of other comprehensive income. Deferred taxes are not provided on cumulative translation adjustments where the Company expects earnings of a foreign subsidiary to be indefinitely reinvested. The income tax effect of currency translation adjustments related to foreign subsidiaries and joint ventures for which earnings are not considered indefinitely reinvested is recorded as a component of deferred taxes with an offset to other comprehensive income.
	Due to a sustained inflationary environment, the financial statements of Clorox Venezuela are consolidated under the rules governing the preparation of financial statements in a highly inflationary economy. As such, Clorox Venezuela's non-U.S. dollar (non-USD) denominated monetary assets and liabilities are remeasured into U.S. dollars (USD) each reporting period with the resulting gains and losses reflected in (losses) earnings from discontinued operations, net.
	Derivative Instruments
The Company's use of derivative instruments, principally swaps, futures and forward contracts, is limited to non-trading purposes and is designed to partially manage exposure to changes in commodity prices, interest rates and foreign currencies. The Company's contracts are hedges for transactions with notional amounts and periods consistent with the related exposures and do not constitute investments independent of these exposures.
Most commodity, interest rate and foreign exchange derivative contracts are designated as cash flow hedges of certain forecasted raw material purchases, interest payments and finished goods inventory purchases, based on certain hedge criteria. The criteria used to determine if hedge accounting treatment is appropriate are: (a) whether the designation of the hedge is to an underlying exposure and (b) whether there is sufficient correlation between the value of the derivative instrument and the underlying obligation. The changes in the fair value of derivatives are recorded as either assets or liabilities in the balance sheet with an offset to net earnings or other comprehensive income depending on whether, for accounting purposes, the derivative is designated and qualifies as a hedge. The Company de-designates cash flow hedge relationships when it determines that the hedge relationships are no longer highly effective or that the forecasted transaction is no longer probable. Upon de-designation of a hedge, the portion of gains or losses on the derivative instrument that was previously accumulated in other comprehensive income remains in accumulated other comprehensive income until the forecasted transaction is recognized in net earnings, or is recognized in net earnings immediately if the forecasted transaction is no longer probable. From time to time, the Company may have contracts not designated as hedges for accounting purposes, for which it recognizes changes in the fair value in other income, net. Cash flows from hedging activities are classified as operating activities in the consolidated statements of cash flows.
The Company uses different methodologies, when necessary, to estimate the fair value of its derivative contracts. The estimated fair values of the majority of the Company's contracts are based on quoted market prices, traded exchange market prices, or broker price quotations, and represent the estimated amounts that the Company would pay or receive to terminate the contracts.

DISCONTINUED_OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Jun. 30, 2014
DISCONTINUED OPERATIONS	'
DISCONTINUED OPERATIONS	'
	NOTE 2. DISCONTINUED OPERATIONS
	On September 22, 2014, Clorox Venezuela announced that it was discontinuing its operations, effective immediately, and seeking to sell its assets. Since fiscal year 2012, Clorox Venezuela was required to sell more than two thirds of its products at prices frozen by the Venezuelan government. During this same period, Clorox Venezuela experienced successive years of hyperinflation resulting in significant sustained increases in its input costs, including packaging, raw materials, transportation and wages. As a result, Clorox Venezuela had been selling its products at a loss, resulting in ongoing operating losses. Clorox Venezuela repeatedly met with government authorities in an effort to help them understand the rapidly declining state of the business, including the need for immediate, significant and ongoing price increases and other critical remedial actions to address these adverse impacts. Based on the Venezuelan government's representations, Clorox Venezuela had expected significant price increases would be forthcoming much earlier; however, the price increases subsequently approved were insufficient and would have caused Clorox Venezuela to continue operating at a significant loss into the foreseeable future. As such, Clorox Venezuela was no longer financially viable and was forced to discontinue its operations.
	On September 26, 2014, the Company reported that Venezuelan Vice President Jorge Arreaza announced, with endorsement by President Nicolás Maduro, that the Venezuelan government had occupied the Santa Lucía and Guacara production facilities of Clorox Venezuela. On November 6, 2014 the Company reported that the Venezuelan government had published a resolution granting a government-sponsored Special Administrative Board full authority to restart and operate the business of Clorox Venezuela, thereby reaffirming the government's expropriation of Clorox Venezuela's assets. Further, President Nicolás Maduro announced the government's intention to facilitate the resumed production of bleach and other cleaning products at Clorox Venezuela plants. He also announced his approval of a financial credit to invest in raw materials and production at the plants. These actions by the Venezuelan government were taken without the consent or involvement of Clorox Venezuela, its parent Clorox Spain S.L. (Clorox Spain) or any of their affiliates. Clorox Venezuela, Clorox Spain and their affiliates reserved their rights under all applicable laws and treaties.
	The following table provides summary net sales results for Clorox Venezuela and a breakdown of losses from discontinued operations for the years ended June 30:
		2014			2013			2012
	Net sales for Clorox Venezuela	$	77		$	90		$	89
	Operating (losses) earnings from Clorox Venezuela before income taxes		(23	)		1			13
	Income tax benefit (expense) attributable to Clorox Venezuela		6			-			(5	)
	Operating (losses) earnings from Clorox Venezuela, net of tax		(17	)		1			8
	Losses from other discontinued operations, net of tax		(4	)		(2	)		(2	)
	(Losses) earnings from discontinued operations, net of tax	$	(21	)	$	(1	)	$	6
	Financial Reporting: Hyperinflation and the Selection of Exchange Rates
	Due to a sustained inflationary environment, the financial statements of Clorox Venezuela are consolidated under the rules governing the preparation of financial statements in a highly inflationary economy. As such, Clorox Venezuela's non-U.S. dollar (non-USD) monetary assets and liabilities are remeasured into U.S. dollars (USD) each reporting period with the resulting gains and losses now reflected in discontinued operations.
	On February 8, 2013, the Venezuelan government announced a devaluation of its currency exchange commission (CADIVI) rate from 4.3 to 6.3 bolivares fuertes (VEF) per USD and the elimination of the alternative currency exchange system, SITME. Prior to February 8, 2013, the Company had been utilizing the rate at which it had been obtaining USD through SITME to remeasure its Venezuelan financial statements, which was 5.7 VEF per USD at the announcement date. In response to these developments, the Company began utilizing the CADIVI rate of 6.3VEF per USD to translate the financial statements of the Venezuela business.
	In March 2013, the Venezuelan government announced the creation of a new alternative currency exchange system, a government-controlled auction process referred to as SICAD I, whereby companies meeting certain qualifications may periodically bid to acquire USD. In January 2014, the Venezuelan government announced further changes to the regulations governing the currency exchange systems. Among the changes was the creation of a new government agency, CENCOEX, to administer the currency exchange mechanism previously administered by CADIVI.
	In February 2014, the Venezuelan government established another currency exchange mechanism, SICAD II, that provides an additional method to exchange VEF at exchange rates significantly higher than the CENCOEX and SICAD I rates. As of June 30, 2014, the posted rate of the SICAD II exchange system was 50.0 VEF per USD. Based on an analysis of the published exchange regulations and an assessment of currency requirements applicable to the Venezuela business, the Company concluded that the SICAD I rate was the most appropriate rate for it to use for financial reporting purposes. The Company began using the SICAD I rate to record the results of business operations and remeasure the gain or loss on non-USD monetary assets and liabilities in Venezuela beginning on March 1, 2014. As a result, the Company recorded a non-tax deductible remeasurement loss of $10 for the year ended June 30, 2014, reflecting the effective devaluation from the CENCOEX rate of 6.3 to the June 30, 2014 posted SICAD I rate of 10.6.
	As of June 30, 2014, using the SICAD I rate of 10.6, the Venezuela business had total assets of $68 including cash and cash equivalents of $5, a long-term value added tax (VAT) receivable from the Venezuelan government of $9, inventories of $11, net property, plant and equipment of $16, and intangible assets excluding goodwill of $6. Goodwill for Venezuela is aggregated and assessed for impairment at the Latin America reporting unit level, which is a component of the Company's International segment. Based on the results of the annual impairment test performed in the fourth quarter of fiscal year 2014, the fair value of the Latin America reporting unit exceeded its recorded value by more than 40%.

BUSINESSES_ACQUIRED

BUSINESSES ACQUIRED	12 Months Ended
	Jun. 30, 2014
BUSINESSES ACQUIRED [Abstract]	'
BUSINESSES ACQUIRED	'
	NOTE 3. BUSINESSES ACQUIRED
	In December 2011, the Company acquired HealthLink, Aplicare, Inc. and Soy Vay Enterprises, Inc., including each business' workforce, for purchase prices aggregating $97, funded through commercial paper borrowings. The cash paid of $93 represents the aggregate purchase prices less cash acquired. Results for HealthLink and Aplicare, Inc., providers of infection control products for the health care industry, are reflected in the Cleaning reportable segment. Results for Soy Vay Enterprises, Inc., a California-based operation that provides the Company a presence in the market for Asian sauces, are reflected in the Lifestyle reportable segment.

INVENTORIES_NET

INVENTORIES, NET	12 Months Ended
	Jun. 30, 2014
INVENTORIES, NET [Abstract]	'
INVENTORIES, NET	'
	NOTE 4. INVENTORIES, NET
	Inventories, net, consisted of the following as of June 30:
		2014			2013
	Finished goods	$	321		$	321
	Raw materials and packaging		113			121
	Work in process		2			3
	LIFO allowances		(36	)		(40	)
	Allowances for obsolescence		(14	)		(11	)
	Total	$	386		$	394
	The last-in, first-out (LIFO) method was used to value approximately 34% and 37% of inventories as of June 30, 2014 and 2013, respectively. The carrying values for all other inventories, including inventories of all international businesses, are determined on the first-in, first-out (FIFO) method. The effect on earnings of the liquidation of LIFO layers was a benefit of $2, $3 and $2 for the fiscal years ended June 30, 2014, 2013 and 2012, respectively.
	The Company had inventory consigned to others of $4 and $2 as of June 30, 2014 and 2013, respectively.
	During fiscal years 2014, 2013 and 2012, the Company's inventory obsolescence expense was $13, $12 and $13, respectively.

OTHER_CURRENT_ASSETS

OTHER CURRENT ASSETS	12 Months Ended
	Jun. 30, 2014
OTHER CURRENT ASSETS [Abstract]	'
OTHER CURRENT ASSETS	'
	NOTE 5. OTHER CURRENT ASSETS
	Other current assets consisted of the following as of June 30:
		2014		2013
	Deferred tax assets	$	81	$	87
	Prepaid expenses		42		41
	Other		11		19
	Total	$	134	$	147
	As of June 30, 2014 and 2013, Other in the table above included $9 and $13 of restricted cash, respectively. As of June 30, 2014 and 2013, restricted cash of $5 and $10, respectively, was held by a foreign subsidiary as a prepayment received for intercompany services. Subsequent to June 30, 2014, this balance is no longer restricted as all services have been performed. Additionally, as of June 30, 2014 and 2013, the Company had restricted cash of $3 and $3, respectively, held in escrow related to fiscal year 2012 acquisitions.

PROPERTY_PLANT_AND_EQUIPMENT_N

PROPERTY, PLANT AND EQUIPMENT, NET	12 Months Ended
	Jun. 30, 2014
PROPERTY, PLANT AND EQUIPMENT, NET [Abstract]	'
PROPERTY, PLANT AND EQUIPMENT, NET	'
	NOTE 6. PROPERTY, PLANT AND EQUIPMENT, NET
	The components of property, plant and equipment, net, consisted of the following as of June 30:
		2014			2013
	Machinery and equipment	$	1,593		$	1,590
	Buildings		506			485
	Capitalized software costs		374			362
	Land and improvements		122			119
	Construction in progress		79			96
	Computer equipment		79			80
			2,753			2,732
	Less: accumulated depreciation and amortization		(1,776	)		(1,711	)
	Total	$	977		$	1,021
	Depreciation and amortization expense related to property, plant and equipment, net, was $161, $162 and $158 in fiscal years 2014, 2013 and 2012, respectively.

GOODWILL_TRADEMARKS_AND_OTHER_

GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS	12 Months Ended
	Jun. 30, 2014
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS [Abstract]	'
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS	'
	NOTE 7. GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS
	Changes in the carrying amount of goodwill, trademarks and other intangible assets for the fiscal years ended June 30, 2014 and 2013, were as follows:
			Goodwill
			Cleaning			Lifestyle			Household			International					Total
	Balance June 30, 2012		$	323		$	244		$	85		$	460				$	1,112
	Translation adjustments and other			-			-			-			(7	)				(7	)
	Balance June 30, 2013		$	323		$	244		$	85		$	453				$	1,105
	Translation adjustments and other			-			-			-			(4	)				(4	)
	Balance June 30, 2014		$	323		$	244		$	85		$	449				$	1,101
		Trademarks									Other intangible assets
		Subject to			Not subject to			Total			Technology				Other				Total
		amortization			amortization						and product
											formulae
	Balance June 30, 2012	$	19		$	537		$	556		$	23			$	63			$	86
	Amortization		(3	)		-			(3	)		(9	)			(6	)			(15	)
	Translation adjustments and other		-			-			-			5				(2	)			3
	Balance June 30, 2013	$	16		$	537		$	553		$	19			$	55			$	74
	Acquisitions and other additions		-			-			-			-				5				5
	Amortization		(1	)		-			(1	)		(9	)			(6	)			(15	)
	Impairment		-			(4	)		(4	)		-				-				-
	Translation adjustments and other		(1	)		-			(1	)		-				-				-
	Balance June 30, 2014	$	14		$	533		$	547		$	10			$	54			$	64
	Intangible assets subject to amortization were net of total accumulated amortization of $291 and $275 as of June 30, 2014 and 2013, respectively, of which $22 and $21, respectively, related to trademarks. Total accumulated amortization included $142 and $136 as of June 30, 2014 and 2013, respectively, related to intangible assets subject to amortization that were fully amortized, of which $13 and $13, respectively, related to trademarks. Estimated amortization expense for these intangible assets is $9, $5, $5, $4 and $3 for fiscal years 2015, 2016, 2017, 2018 and 2019, respectively.
	In fiscal year 2014, the Company entered into an exclusivity agreement with a manufacturer. In connection with the agreement, the Company recorded an Other Intangible Asset valued at $4 that will be amortized over the 7-year term of the agreement. The agreement may be renewed for an additional 3 years at no cost upon mutual consent.
	As a result of the effective devaluation of the Venezuelan currency in the third quarter of fiscal year 2014, the Company assessed whether recorded values of intangible assets attributable to the Venezuela subsidiary and goodwill of the reporting unit which included Venezuela were impaired. As a result of its assessment, the Company identified indications of impairment and recorded noncash tax deductible impairment charges on trademark values totaling $4 , which is reflected in the International reportable segment, Of this amount $3 is related to continuing operations and is reflected in other income, net and $1 is related to trademarks held on the books of Clorox Venezuela and is reflected in earnings from discontinued operations, net. The Company used an income approach, the relief-from-royalty method, to estimate the fair value of the trademarks, and as such, the fair value measurement was classified as Level 3. For a further discussion of Clorox Venezuela's intangible and other asset balances, refer to Note 2 – Discontinued Operations.
	During the fourth quarter of fiscal years 2014, 2013 and 2012, the Company completed its annual impairment tests of goodwill and indefinite-lived intangible assets and no instances of impairment were identified.

ACCRUED_LIABILITIES

ACCRUED LIABILITIES	12 Months Ended
	Jun. 30, 2014
ACCRUED LIABILITIES [Abstract]	'
ACCRUED LIABILITIES	'
	NOTE 8. ACCRUED LIABILITIES
	Accrued liabilities consisted of the following as of June 30:
		2014		2013
	Trade and sales promotion	$	113	$	116
	Compensation and employee benefit costs		102		152
	Dividends		100		96
	Interest		27		27
	Insurance		18		20
	Derivatives		17		3
	Royalties		11		11
	Other		84		65
	Total	$	472	$	490

DEBT

DEBT	12 Months Ended
	Jun. 30, 2014
DEBT [Abstract]	'
DEBT	'
	NOTE 9. DEBT
	Notes and loans payable, which mature in less than one year, included the following as of June 30:
			2014			2013
	Commercial paper		$	141		$	200
	Foreign borrowings			2			2
	Total		$	143		$	202
	The weighted average interest rates incurred on average outstanding notes and loans payable during the fiscal years ended June 30, 2014, 2013 and 2012, including fees associated with the Company's undrawn revolving credit facility, were 0.97%, 1.68% and 0.85%, respectively. The weighted average effective interest rates on commercial paper balances as of June 30, 2014 and 2013, were 0.28% and 0.31%, respectively. The carrying value of notes and loans payable as of June 30, 2014 and 2013, approximated their fair value due to their short maturity.
	Long-term debt, carried at face value net of unamortized discounts or premiums, included the following as of June 30:
		2014			2013
	Senior unsecured notes and debentures:
	5.00%, $575 due January 2015	$	575		$	575
	3.55%, $300 due November 2015		300			300
	5.95%, $400 due October 2017		399			399
	3.80%, $300 due November 2021		298			298
	3.05%, $600 due September 2022		598			598
	Total		2,170			2,170
	Less: Current maturities of long-term debt		(575	)		-
	Long-term debt	$	1,595		$	2,170
	The weighted average interest rates incurred on average outstanding long-term debt during the fiscal years ended June 30, 2014, 2013 and 2012, were 4.56%, 4.76% and 5.21%, respectively. The weighted average effective interest rate on long-term debt balances as of June 30, 2014 and 2013, was 4.56%.
	In March 2013, $500 in senior notes with an annual fixed interest rate of 5.00% became due and were repaid. The repayment was funded in part with commercial paper borrowings and in part with a portion of the proceeds from the sale-leaseback transaction of the Company's Oakland, Calif., general office building (Note 11 – Other Liabilities).
	In October 2012, $350 in senior notes with an annual fixed interest rate of 5.45% became due and were repaid. The repayment was funded with a portion of the proceeds from the September 2012 issuance of $600 in senior notes with an annual fixed interest rate of 3.05%, payable semi-annually in March and September, and a maturity date of September 15, 2022. The remaining proceeds from the September 2012 issuance were used to repay commercial paper.
	In November 2011, the Company issued $300 in senior notes with an annual fixed interest rate of 3.80%, payable semi-annually in May and November, and a maturity date of November 15, 2021. Proceeds from the notes were used to repay commercial paper.
	The senior notes issued in September 2012 and November 2011 rank equally and ratably in right of payment with all of the Company's existing and future senior unsecured indebtedness and senior to any future subordinated unsecured indebtedness. These notes were issued under the Company's shelf registration statement filed in November 2011, which allows the Company to offer and sell an unlimited amount of its senior unsecured indebtedness from time to time and expires in November 2014.
	As of June 30, 2014, the Company had interest rate forward contracts with a notional amount of $288 related to the anticipated refinancing of senior notes maturing in January 2015.
	The Company's borrowing capacity under other financing arrangements as of June 30 was as follows:
			2014			2013
	Revolving credit facility		$	1,100		$	1,100
	Foreign credit lines			31			32
	Other credit lines			13			13
	Total		$	1,144		$	1,145
	As of June 30, 2014, the Company had a $1.1 billion revolving credit agreement, which expires in May 2017. There were no borrowings under the agreement, and the Company believes that borrowings under the revolving credit facility are and will continue to be available for general corporate purposes. The agreement includes certain restrictive covenants and limitations, with which the Company was in compliance as of June 30, 2014.
	Of the $44 of foreign and other credit lines as of June 30, 2014; $5 was outstanding and the remainder of $39 was available for borrowing. As of June 30, 2014, $7 of foreign credit lines related to Clorox Venezuela, of which $1 was outstanding.
	Long-term debt maturities as of June 30, 2014, are $575, $300, $0, $400, $0 and $900 in fiscal years 2015, 2016, 2017, 2018, 2019 and thereafter, respectively.

FINANCIAL_INSTRUMENTS_AND_FAIR

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS	12 Months Ended
	Jun. 30, 2014
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]	'
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS	'
	NOTE 10. FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
	Financial assets and liabilities carried at fair value in the consolidated balance sheets are required to be classified and disclosed in one of the following three categories:
	Level 1: Quoted market prices in active markets for identical assets or liabilities.
	Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
	Level 3: Unobservable inputs reflecting the reporting entity's own assumptions.
	As of June 30, 2014, the Company's financial assets and liabilities that were measured at fair value on a recurring basis during the period included derivative financial instruments, which were all classified as Level 2, and trust assets to fund certain of the Company's nonqualified deferred compensation plans, which were classified as Level 1. As of June 30, 2013, the Company's financial assets and liabilities that were measured at fair value on a recurring basis during the period included derivative financial instruments, which were all classified as Level 2.
	Financial Risk Management and Derivative Instruments
	The Company is exposed to certain commodity, interest rate and foreign currency risks related to its ongoing business operations and uses derivative instruments to mitigate its exposure to these risks.
	Commodity Price Risk Management
	The Company may use commodity exchange traded futures and over-the-counter swap contracts to fix the price of a portion of its forecasted raw material requirements. Contract maturities, which are generally no longer than 2 years, are matched to the length of the raw material purchase contracts. Commodity purchase contracts are measured at fair value using market quotations obtained from commodity derivative dealers.
	As of June 30, 2014, the notional amount of commodity derivatives was $36, of which $19 related to jet fuel swaps and $17 related to soybean oil futures. As of June 30, 2013, the notional value of commodity derivatives was $51, of which $32 related to jet fuel swaps and $19 related to soybean oil futures.
	Interest Rate Risk Management
	The Company may enter into over-the-counter interest rate forward contracts to fix a portion of the benchmark interest rate prior to the anticipated issuance of fixed rate debt. These interest rate forward contracts generally have durations of less than twelve months. The interest rate contracts are measured at fair value using information quoted by U.S. government bond dealers. During fiscal years 2014 and 2013, the Company paid $0 and $4 to settle interest rate forward contracts, respectively, which were reflected in operating cash flows.
	As of June 30, 2014 and 2013, the notional amount of interest rate forward contracts was $288 and $0, respectively. The interest rate forward contracts outstanding as of June 30, 2014, were related to the anticipated refinancing of senior notes maturing in January 2015.
	Foreign Currency Risk Management
	The Company may also enter into certain over-the-counter foreign currency-related derivative contracts to manage a portion of the Company's foreign exchange risk associated with the purchase of inventory and certain intercompany transactions. These foreign currency contracts generally have durations of no longer than 20 months. The foreign exchange contracts are measured at fair value using information quoted by foreign exchange dealers.
	The notional amount of outstanding foreign currency forward contracts used by the Company's subsidiaries in Canada, Australia and New Zealand to hedge forecasted purchases of inventory were $54, $28 and $5, respectively, as of June 30, 2014, and $18, $22 and $4, respectively, as of June 30, 2013. There were no outstanding contracts to economically hedge foreign exchange risk associated with intercompany transactions as of June 30, 2014 and 2013, respectively.
	Counterparty Risk Management
	The Company utilizes a variety of financial institutions as counterparties for over-the counter derivative instruments. The Company enters into agreements governing the use of over-the-counter derivative instruments and sets internal limits on the aggregate over-the-counter derivative instrument positions held with each counterparty. Certain terms of these agreements require the Company or the counterparty to post collateral when the fair value of the derivative instruments exceeds contractually defined counterparty liability position limits. Of the $17 and $3 of the derivative instruments reflected in accrued liabilities as of June 30, 2014 and 2013, respectively, $11 and $3, respectively, contained such terms. As of both June 30, 2014 and 2013, neither the Company nor any counterparty was required to post any collateral.
	Certain terms of the agreements governing the Company's over-the-counter derivative instruments require the credit ratings, as assigned by Standard & Poor's and Moody's to the Company and its counterparties, to remain at a level equal to or better than the minimum of an investment grade credit rating. If the Company's credit ratings were to fall below investment grade, the counterparties to the derivative instruments could request full collateralization on derivative instruments in net liability positions. As of both June 30, 2014 and 2013, the Company and each of its counterparties had been assigned investment grade ratings with both Standard & Poor's and Moody's.
	Fair Value of Financial Instruments
	Derivatives
	The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as an accounting hedge and, if so, on the type of hedging relationship. For those derivative instruments designated and qualifying as hedging instruments, the Company must designate the hedging instrument as a fair value hedge or a cash flow hedge. The Company designates its commodity forward and future contracts for forecasted purchases of raw materials, interest rate forward contracts for forecasted interest payments, and foreign currency forward contracts for forecasted purchases of inventory as cash flow hedges. The Company does not designate its foreign currency forward contracts for intercompany transactions as accounting hedges. During the fiscal years ended June 30, 2014, 2013 and 2012, the Company had no hedging instruments designated as fair value hedges.
	Trust Assets
	Beginning in December 2013, the Company holds mutual funds and cash equivalents as part of trusts related to certain of its nonqualified deferred compensation plans. The trusts represent variable interest entities, for which the Company is considered the primary beneficiary, and therefore, trust assets are consolidated and included in other assets in the condensed consolidated balance sheets. The mutual funds are measured at fair value using quoted market prices. The Company has designated these marketable securities as trading investments. The participants in the deferred compensation plans may select among certain mutual funds in which their compensation deferrals are invested in accordance with the terms of the plans and within the confines of the trusts which hold the marketable securities.
	The Company's derivative instruments designated as hedging instruments and trust assets related to certain of the Company's nonqualified deferred compensation plans were recorded at fair value in the consolidated balance sheets as of June 30 as follows:
					2014								2013
		Balance sheet
		classification			Level 1				Level 2				Level 1				Level 2
	Assets
	Foreign exchange derivative contracts	Other current assets			$	-			$	-			$	-			$	4
	Commodity purchase derivative contracts	Other current assets				-				1				-				-
	Trust assets for nonqualified deferred
	compensation plans	Other assets				31				-				-				-
					$	31			$	1			$	-			$	4
	Liabilities
	Commodity purchase derivative contracts	Accrued liabilities			$	-			$	1			$	-			$	3
	Interest rate derivative contracts	Accrued liabilities				-				13				-				-
	Foreign exchange derivative contracts	Accrued liabilities				-				3				-				-
					$	-			$	17			$	-			$	3
	For derivative instruments designated and qualifying as cash flow hedges, the effective portion of gains or losses is reported as a component of other comprehensive income (OCI) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The estimated amount of the existing net loss in OCI as of June 30, 2014, expected to be reclassified into earnings within the next twelve months is $8. Gains and losses on derivative instruments representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. During each of the fiscal years ended June 30, 2014, 2013 and 2012, hedge ineffectiveness was not significant.
	The effects of derivative instruments designated as hedging instruments on OCI and the consolidated statements of earnings were as follows during the fiscal years ended June 30:
			Gains (losses) recognized in OCI												Gains (losses) reclassified from OCI
															and recognized in earnings
			2014				2013				2012				2014				2013			2012
	Commodity purchase derivative contracts		$	2			$	(1	)		$	(1	)		$	-			$	-		$	4
	Interest rate derivative contracts			(13	)			(1	)			(39	)			(4	)			(3	)		(2	)
	Foreign exchange derivative contracts			(3	)			3				3				4				-			2
	Total		$	(14	)		$	1			$	(37	)		$	-			$	(3	)	$	4
	The gains reclassified from OCI and recognized in earnings during the fiscal years ended June 30, 2014 and 2012, for commodity purchase and foreign exchange contracts were included in cost of products sold. The losses reclassified from OCI and recognized in earnings during the fiscal years ended June 30, 2014, 2013 and 2012, for interest rate contracts were included in interest expense.
	Changes in the value of the trust assets related to certain of the Company's nonqualified deferred compensation plans were $(1) for the fiscal year ended June 30, 2014, and were reflected in other income, net, in the consolidated statements of earnings.
	Other
	The carrying values of cash and cash equivalents, accounts receivable and accounts payable approximate their fair values as of June 30, 2014 and 2013, due to their short maturity and nature. The estimated fair value of long-term debt, including current maturities, was $2,265 and $2,263 as of June 30, 2014 and 2013, respectively. The fair value of long-term debt was determined using secondary market prices quoted by corporate bond dealers, and was classified as Level 2.

OTHER_LIABILITIES

OTHER LIABILITIES	12 Months Ended
	Jun. 30, 2014
OTHER LIABILITIES [Abstract]	'
OTHER LIABILITIES	'
	NOTE 11. OTHER LIABILITIES
	Other liabilities consisted of the following as of June 30:
		2014		2013
	Venture agreement net terminal obligation	$	290	$	284
	Employee benefit obligations		289		270
	Taxes		76		74
	Other		113		114
	Total	$	768	$	742
	Venture Agreement
	The Company has an agreement with The Procter & Gamble Company (P&G) for its Glad® plastic bags, wraps and containers business. The Company maintains a net terminal obligation liability, which reflects the estimated value of the contractual requirement to repurchase P&G's interest at the termination of the agreement. As of June 30, 2014 and 2013, P&G had a 20% interest in the venture. The Company pays a royalty to P&G for its interest in the profits, losses and cash flows, as contractually defined, of the Glad® business, which is included in cost of products sold.
	The agreement, entered into in 2003, has a 20-year term, with a 10-year renewal option and can be terminated under certain circumstances, including at P&G's option upon a change in control of the Company or, at either party's option, upon the sale of the Glad® business by the Company. Upon termination of the agreement, the Company will purchase P&G's interest for cash at fair value as established by predetermined valuation procedures. Following termination, the Glad® business will retain the exclusive core intellectual property licenses contributed by P&G on a royalty-free basis for the licensed products marketed.
	Deferred Gain on Sale-leaseback Transaction
	In December 2012, the Company completed a sale-leaseback transaction under which it sold its general office building in Oakland, Calif., to an unrelated party for net proceeds of $108 and entered into a 15-year operating lease agreement with renewal options with the buyer for a portion of the building. The Company deferred recognition of the portion of the total gain on the sale that was equivalent to the present value of the lease payments and will continue to amortize such amount to earnings ratably over the lease term. As of June 30, 2014 and 2013, the long-term portion of the deferred gain of $43 and $47, respectively, was included in Other in the table above.

OTHER_CONTINGENCIES_AND_GUARAN

OTHER CONTINGENCIES AND GUARANTEES	12 Months Ended
	Jun. 30, 2014
OTHER CONTINGENCIES AND GUARANTEES [Abstract]	'
OTHER CONTINGENCIES AND GUARANTEES	'
	NOTE 12. OTHER CONTINGENCIES AND GUARANTEES
	Contingencies
	The Company is involved in certain environmental matters, including response actions at various locations. The Company had a recorded liability of $14 and $13 as of June 30, 2014 and 2013, respectively, for its share of aggregate future remediation costs related to these matters. One matter in Dickinson County, Michigan, for which the Company is jointly and severally liable, accounted for a substantial majority of the recorded liability as of both June 30, 2014 and 2013. The Company has agreed to be liable for 24.3% of the aggregate remediation and associated costs for this matter pursuant to a cost-sharing arrangement with a third party. With the assistance of environmental consultants, the Company maintains an undiscounted liability representing its current best estimate of its share of the capital expenditures, maintenance and other costs that may be incurred over an estimated 30-year remediation period. Currently, the Company cannot accurately predict the timing of future payments that may be made under this obligation. In addition, the Company's estimated loss exposure is sensitive to a variety of uncertain factors, including the efficacy of remediation efforts, changes in remediation requirements and the future availability of alternative clean-up technologies. Although it is reasonably possible that the Company's exposure may exceed the amount recorded, any amount of such additional exposures, or range of exposures, is not estimable at this time.
	In October 2012, a Brazilian appellate court issued an adverse decision in a lawsuit pending in Brazil against the Company and one of its wholly owned subsidiaries, The Glad Products Company (Glad). The lawsuit was initially filed in a Brazilian lower court in 2002 by two Brazilian companies and one Uruguayan company (collectively, Petroplus) related to joint venture agreements for the distribution of STP auto-care products in Brazil with three companies that became subsidiaries of the Company as a result of the Company's merger with First Brands Corporation in January 1999 (collectively, Clorox Subsidiaries). The pending lawsuit seeks indemnification for damages and losses for alleged breaches of the joint venture agreements and abuse of economic power by the Company and Glad. Petroplus had previously unsuccessfully raised the same claims and sought damages from the Company and the Clorox Subsidiaries in an International Chamber of Commerce (ICC) arbitration proceeding in Miami, Florida, filed in 2001. The ICC arbitration panel unanimously ruled against Petroplus in a final decision in November 2003 (Final ICC Arbitration Award). The Final ICC Arbitration Award was ratified by the Superior Court of Justice of Brazil in May 2007 (Foreign Judgment), and the United States District Court for the Southern District of Florida subsequently confirmed the Final ICC Arbitration Award and recognized and adopted the Foreign Judgment as a judgment of the United States District Court for the Southern District of Florida (U.S. Judgment). Despite this, in March 2008, a Brazilian lower court ruled against the Company and Glad in the pending lawsuit and awarded Petroplus R$23 ($13) plus interest. The value of that judgment, including interest and foreign exchange fluctuations as of June 30, 2014, was approximately $39.
	Among other defenses, because the Final ICC Arbitration Award, the Foreign Judgment and the U.S. Judgment relate to the same claims as those in the pending lawsuit, the Company believes that Petroplus is precluded from re-litigating these claims. Based on the unfavorable appellate court decision, the Company believes that it is reasonably possible that a loss could be incurred in this matter in excess of amounts accrued, and that the estimated range of such loss in this matter is from $0 to $33. The Company continues to believe that its defenses are meritorious, and has appealed the decision to the highest courts of Brazil. In the first stage of the appellate process, in December 2013, the appellate court declined to admit the Company's appeals to the highest courts. The Company then appealed directly to the highest courts and in May 2014, the Supreme Court of Justice agreed to consider the Company's appeal. Expenses related to this litigation and any potential additional loss would be reflected in discontinued operations, consistent with the Company's classification of expenses related to its discontinued Brazil operations.
	In a separate action filed in 2004 by Petroplus, a lower Brazilian court in January 2013 nullified the Final ICC Arbitration Award. The Company believes this judgment is inconsistent with the Foreign Judgment and the U.S. Judgment and that it is without merit. The Company appealed this decision, and the lower court decision was overturned by the appellate court in April 2014. Petroplus has appealed this decision to Brazil's highest court.
	Glad and the Clorox Subsidiaries have also filed separate lawsuits against Petroplus alleging misuse of the STP trademark and related matters, which are currently pending before Brazilian courts, and have taken other legal actions against Petroplus, which are pending. Additionally, in November 2013, the Clorox Subsidiaries initiated a new ICC arbitration seeking damages against Petroplus.
	The Company is subject to various lawsuits, claims and other loss contingencies relating to issues such as contract disputes, product liability, patents and trademarks, advertising, and employee and other matters. Based on management's analysis, it is the opinion of management that the ultimate disposition of these matters, to the extent not previously provided for, will not have a material adverse effect, individually or in the aggregate, on the Company's consolidated financial statements taken as a whole.
	Guarantees
	In conjunction with divestitures and other transactions, the Company may provide typical indemnifications (e.g., indemnifications for representations and warranties and retention of previously existing environmental, tax and employee liabilities) that have terms that vary in duration and in the potential amount of the total obligation and, in many circumstances, are not explicitly defined. The Company has not made, nor does it believe that it is probable that it will make, any payments relating to its indemnifications, and believes that any reasonably possible payments would not have a material adverse effect, individually or in the aggregate, on the Company's consolidated financial statements taken as a whole.
	The Company had not recorded any liabilities on the aforementioned guarantees as of June 30, 2014 and 2013.
	As of June 30, 2014, the Company was a party to letters of credit of $12, primarily related to one of its insurance carriers, of which $0 had been drawn upon.

STOCKHOLDERS_EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Jun. 30, 2014
STOCKHOLDERS' EQUITY [Abstract]	'
STOCKHOLDERS' EQUITY	'
	NOTE 13. STOCKHOLDERS' EQUITY
	On May 13, 2013, the Company's board of directors terminated the share repurchase programs previously authorized on May 13, 2008, and May 18, 2011, and authorized a new share repurchase program for an aggregate purchase amount of up to $750. This open market share repurchase program is in addition to the Company's evergreen repurchase program (Evergreen Program), the purpose of which is to offset the impact of stock dilution related to stock-based awards. The Evergreen Program has no authorization limit as to amount or timing of repurchases.
	Share repurchases under authorized programs were as follows during the fiscal years ended June 30:
		2014							2013							2012
		Amount			Shares				Amount			Shares				Amount		Shares
					0							0						0
	Open-market purchase programs	$	-			-			$	-			-			$	158		2,429
	Evergreen Program		260			3,046				128			1,500				67		990
	Total	$	260			3,046			$	128			1,500			$	225		3,419
	During fiscal years 2014, 2013 and 2012, the Company declared dividends per share of $2.87, $2.63 and $2.44, respectively, and paid dividends per share of $2.84, $2.56 and $2.40, respectively.
	In February 2013, the FASB issued an update to current accounting standards related to disclosures of reclassifications out of accumulated other comprehensive income. The presentation requirements were adopted by the Company effective July 1, 2013, and are reflected below.
	Changes in accumulated other comprehensive net losses by component were as follows:
		Foreign				Net unrealized				Pension and				Total
		currency				(losses) gains on				postretirement
		translation				derivatives				benefit
		adjustments								adjustments
	Balance as of June 30, 2012, net of tax	$	(198	)		$	(33	)		$	(165	)		$	(396	)
	Other comprehensive (loss) income
	before reclassifications		(11	)			-				31				20
	Amounts reclassified from accumulated other
	comprehensive net losses		-				3				6				9
	Net other comprehensive (loss) income		(11	)			3				37				29
	Balance as of June 30, 2013, net of tax	$	(209	)		$	(30	)		$	(128	)		$	(367	)
	Other comprehensive losses
	before reclassifications		(37	)			(9	)			(9	)			(55	)
	Amounts reclassified from accumulated other
	comprehensive net losses		-				-				5				5
	Net other comprehensive losses		(37	)			(9	)			(4	)			(50	)
	Balance as of June 30, 2014, net of tax	$	(246	)		$	(39	)		$	(132	)		$	(417	)
	Pension and postretirement benefit reclassification adjustments are reflected in cost of products sold and selling and administrative expenses.

NET_EARNINGS_PER_SHARE_EPS

NET EARNINGS PER SHARE (EPS)	12 Months Ended
	Jun. 30, 2014
NET EARNINGS PER SHARE (EPS) [Abstract]	'
NET EARNINGS PER SHARE (EPS)	'
	NOTE 14. NET EARNINGS PER SHARE (EPS)
	The following is the reconciliation of the weighted average number of shares outstanding (in thousands) used to calculate basic net EPS to those used to calculate diluted net EPS:
		2014	2013	2012
	Basic	129,558	131,075	130,852
	Dilutive effect of stock options and other	2,184	1,894	1,458
	Diluted	131,742	132,969	132,310
	During fiscal years 2014 and 2013, the Company included all stock options to purchase shares of the Company's common stock in the calculations of diluted net EPS because the average market price was greater than the exercise price of all outstanding options.
	During fiscal year 2012, the Company did not include stock options to purchase approximately 1.8 million shares of the Company's common stock in the calculations of diluted net EPS because their exercise price was greater than the average market price, making them anti-dilutive.

STOCKBASED_COMPENSATION_PLANS

STOCK-BASED COMPENSATION PLANS	12 Months Ended
	Jun. 30, 2014
STOCK-BASED COMPENSATION PLANS [Abstract]	'
STOCK-BASED COMPENSATION PLANS	'
	NOTE 15. STOCK-BASED COMPENSATION PLANS
	In November 2012, the Company's stockholders voted to approve the amended and restated 2005 Stock Incentive Plan (Plan). The Plan permits the Company to grant various nonqualified stock-based compensation awards, including stock options, restricted stock, performance units, deferred stock units, stock appreciation rights and other stock-based awards. The primary amendment reflected in the Plan was an increase of approximately 3 million common shares that may be issued for stock-based compensation purposes. As of June 30, 2014, the Company is authorized to grant up to approximately 7 million common shares under the Plan and, as of June 30, 2014, approximately 6 million shares were available for grant.
	Compensation cost and the related income tax benefit recognized for stock-based compensation plans were classified as indicated below for the fiscal years ended June 30.
				2014			2013			2012
	Cost of products sold			$	4		$	4		$	3
	Selling and administrative expenses				29			28			22
	Research and development costs				3			3			2
	Total compensation cost			$	36		$	35		$	27
	Related income tax benefit			$	13		$	13		$	10
	Cash received during fiscal years 2014, 2013 and 2012 from stock options exercised under all stock-based payment arrangements was $86, $121 and $79, respectively. The Company issues shares for stock-based compensation plans from treasury stock. The Company may repurchase shares under its Evergreen Program to offset the estimated impact of share dilution related to stock-based awards (Note 13 – Stockholders' Equity).
	Details regarding the valuation and accounting for stock options, restricted stock awards, performance units and deferred stock units for non-employee directors follow.
	Stock Options
	The fair value of each stock option award granted during fiscal years 2014, 2013 and 2012 was estimated on the date of grant using the Black-Scholes valuation model and assumptions noted in the following table:
			2014				2013				2012
	Expected life			5.7 years				5.7 years				4.9 - 5.7 years
	Weighted-average expected life			5.7 years				5.7 years				5.7 years
	Expected volatility			18.4% to 18.5%				18.7% to 19.2%				21.9% to 25.9%
	Weighted-average volatility			18.50%				19.10%				23.50%
	Risk-free interest rate			1.8% to 1.9%				0.6% to 0.8%				0.9% to 1.1%
	Weighted-average risk-free interest rate			1.80%				0.70%				0.90%
	Dividend yield			3.40%				3.2%-3.6%				3.5%-3.8%
	Weighted-average dividend yield			3.40%				3.60%				3.50%
	The expected life of the stock options is based on observed historical exercise patterns. Groups of employees having similar historical exercise behavior are considered separately for valuation purposes. The Company estimates stock option forfeitures based on historical data for employee groups. The total number of stock options expected to vest is adjusted by actual and estimated forfeitures.
	The expected volatility is based on implied volatility from publicly traded options on the Company's stock at the date of grant, historical implied volatility of the Company's publicly traded options and other factors. The risk-free interest rate is based on the implied yield on a U.S. Treasury zero-coupon issue with a remaining term equal to the expected term of the option. The dividend yield is based on the projected annual dividend payment per share, divided by the stock price at the date of grant.
	Details of the Company's stock option activities are summarized below:
			Number of				Weighted-		Average				Aggregate
			Shares				Average		Remaining				Intrinsic
							Exercise		Contractual				Value
							Price		Life
							per Share
			(In thousands)
	Options outstanding as of June 30, 2013			10,257			$	65		7 years			$	184
	Granted			1,795				84
	Exercised			(1,450	)			60
	Cancelled			(234	)			75
	Options outstanding as of June 30, 2014			10,368			$	69		6 years			$	232
	Options vested as of June 30, 2014			5,772			$	64		5 years			$	159
	The weighted-average fair value per share of each option granted during fiscal years 2014, 2013 and 2012, estimated at the grant date using the Black-Scholes option pricing model, was $9.69, $6.96 and $9.24, respectively. The total intrinsic value of options exercised in fiscal years 2014, 2013 and 2012 was $42, $45 and $29, respectively.
	Stock option awards outstanding as of June 30, 2014, have been granted at prices that are either equal to or above the market value of the stock on the date of grant. Stock option grants generally vest over four years and expire no later than ten years after the grant date. The Company recognizes compensation expense ratably over the vesting period. As of June 30, 2014, there was $17 of total unrecognized compensation cost related to non-vested options, which is expected to be recognized over a remaining weighted-average vesting period of one year, subject to forfeiture changes.
	Restricted Stock Awards
	The fair value of restricted stock awards is estimated on the date of grant based on the market price of the stock and is amortized to compensation expense on a straight-line basis over the related vesting periods, which are generally three to four years. The total number of restricted stock awards expected to vest is adjusted by actual and estimated forfeitures. Restricted stock grants receive dividend distributions earned during the vesting period upon vesting.
	As of June 30, 2014, there was $1 of total unrecognized compensation cost related to non-vested restricted stock awards, which is expected to be recognized over a remaining weighted-average vesting period of one year. The total fair value of the shares that vested in fiscal years 2014, 2013 and 2012 was less than $1, $1 and $3, respectively. The weighted-average grant-date fair value of awards granted was $89.25, $72.28 and $68.52 per share for fiscal years 2014, 2013 and 2012, respectively.
	A summary of the status of the Company's restricted stock awards as of June 30 is presented below:
		Number of			Weighted-Average
		Shares			Grant Date
					Fair Value
					per Share
		(In thousands)
	Restricted stock awards as of June 30, 2013	11			$	68
	Granted	13				89
	Vested	(3	)			67
	Forfeited	-				-
	Restricted stock awards as of June 30, 2014	21			$	81
	Performance Units
	The Company's performance unit grants provide for the issuance of common stock to certain managerial staff and executive management if the Company achieves certain performance targets. The performance period is three years and the final payout determination is made at the end of the three-year performance period. Performance unit grants receive dividends earned during the vesting period upon vesting.
	The fair value of each grant issued is estimated on the date of grant based on the current market price of the stock. The total amount of compensation expense recognized reflects actual and estimated forfeitures, and the initial assumption that performance goals will be achieved. Compensation expense is adjusted, as necessary, on a quarterly basis based on management's assessment of the probability that performance goals will be achieved. If such goals are not met or it is determined that achievement of performance goals is not probable, any previously recognized compensation expense is adjusted in the current period to reflect the expected payout level. If it is determined that the performance goals will be exceeded, additional compensation expense is recognized, subject to a cap of 150% of the grant day target.
	The number of shares issued will be dependent upon vesting and the achievement of specified performance targets. As of June 30, 2014, there was $19 in unrecognized compensation cost related to non-vested performance unit grants that is expected to be recognized over a remaining weighted-average performance period of one year. The weighted-average grant-date fair value of awards granted was $84.45, $72.11 and $68.17 per share for fiscal years 2014, 2013 and 2012, respectively.
	A summary of the status of the Company's performance unit awards as of June 30 is presented below:
		Number of			Weighted-Average
		Shares			Grant Date
					Fair Value
					per Share
		(In thousands)
Performance unit awards as of June 30, 2013	1,335			$	66
Granted	347				84
Distributed	(35	)			54
Forfeited	(426	)			67
Performance unit awards as of June 30, 2014	1,221			$	73
Perfomance units vested and deferred as of June 30, 2014	168			$	56
The non-vested performance units outstanding as of June 30, 2014 and 2013, were 1,053,000 and 1,116,000, respectively, and the weighted average grant date fair value was $74.68 and $69.01 per share, respectively. No shares vested during fiscal year 2014. The total fair value of shares vested was $0, $14 and $34 during fiscal years 2014, 2013 and 2012, respectively. Upon vesting, the recipients of the grants receive the distribution as shares or, if previously elected by eligible recipients, as deferred stock. During fiscal year 2013, $13 of the vested awards was paid by the issuance of shares. During fiscal year 2013, $1 of the vested awards was deferred. Deferred shares continue to earn dividends, which are also deferred.
Deferred Stock Units for Nonemployee Directors
Nonemployee directors receive annual grants of deferred stock units under the Company's director compensation program and can elect to receive all or a portion of their annual retainers and fees in the form of deferred stock units. The deferred stock units receive dividend distributions, which are reinvested as deferred stock units, and are recognized at their fair value on the date of grant. Each deferred stock unit represents the right to receive one share of the Company's common stock following the completion of a director's service.
During fiscal year 2014, the Company granted 16,000 deferred stock units, reinvested dividends of 7,000 units and distributed 23,000 shares, which had a weighted-average fair value on grant date of $91.79, $88.96 and $66.79 per share, respectively. As of June 30, 2014, 233,000 units were outstanding, which had a weighted-average fair value on the grant date of $62.84 per share.

LEASES_AND_OTHER_COMMITMENTS

LEASES AND OTHER COMMITMENTS	12 Months Ended
	Jun. 30, 2014
LEASES AND OTHER COMMITMENTS [Abstract]	'
LEASES AND OTHER COMMITMENTS	'
	NOTE 16. LEASES AND OTHER COMMITMENTS
	The Company leases transportation equipment, certain information technology equipment and various manufacturing, warehousing, and office facilities. The Company's leases are classified as operating leases, and the Company's existing contracts will expire by 2027. The Company expects that, in the normal course of business, existing contracts will be renewed or replaced by other leases. Rental expense for all operating leases was $71, $71 and $68 in fiscal years 2014, 2013 and 2012, respectively. The future minimum rental payments required under the Company's existing non-cancelable lease agreements as of June 30, 2014, are expected to be $47, $45, $41, $37, $32 and $127 in fiscal years 2015, 2016, 2017, 2018, 2019 and thereafter, respectively.
	The future minimum rental payments required under the Company's existing non-cancelable lease agreement's for the corporate headquarters and primary research and development facility as of June 30, 2014, are expected to be $10, $11, $11, $11, $11 and $69 in fiscal years 2015, 2016, 2017, 2018, 2019 and thereafter, respectively. These amounts are included in the Company's future minimum rental payments disclosed above.
	The Company is also a party to certain purchase obligations, which are defined as purchase agreements that are enforceable and legally binding and that contain specified or determinable significant terms, including quantity, price and the approximate timing of the transaction. Examples of the Company's purchase obligations include contracts to purchase raw materials, commitments to contract manufacturers, commitments for information technology and related services, advertising contracts, utility agreements, capital expenditure agreements, software acquisition and license commitments and service contracts. Approximately 17% of the Company's purchase obligations in fiscal years 2015 through 2019 relate to service contracts for information technology that has been outsourced. The contracts included above are entered into during the regular course of business based on expectations of future needs. Many of these contracts are short term in nature and are flexible to allow for changes in the Company's business and related requirements. As of June 30, 2014, the Company's purchase obligations, including the services related to information technology, totaled $246, $87, $65, $51, $33 and $7 for fiscal years 2015, 2016, 2017, 2018, 2019 and thereafter, respectively.

OTHER_INCOME_NET

OTHER INCOME, NET	12 Months Ended
	Jun. 30, 2014
OTHER INCOME, NET [Abstract]	'
OTHER INCOME, NET	'
	NOTE 17. OTHER INCOME, NET
	The major components of other income, net, for the fiscal years ended June 30 were:
		2014		2013		2012
	Income from equity investees	$	-13	$	-12	$	-11
	Insurance and other settlements		-5		-		-
	Interest income		-3		-3		-3
	Income from transition and related services		-1		-3		-6
	Amortization of trademarks and other intangible assets (Note 7)		8		9		9
	Intangible asset impairment charges (Note 7)		3		-		-
	Foreign exchange transaction losses, net (Note 1)		1		8		1
	Low-income housing partnership gains and other, net		-		-3		-2
	Total	$	-10	$	-4	$	-12
	Investment in Low-Income Housing Partnerships
	The Company owns, directly or indirectly, limited partnership interests in low-income housing partnerships, which are accounted for using the equity method of accounting. The Company's investment balance as of June 30, 2014 and 2013, was $4 and $6, respectively. These partnerships are considered to be variable interest entities; however, the Company does not consolidate them because it does not have the power to direct the partnerships' activities that significantly impact their economic performance. The purpose of the partnerships is to develop and operate low-income housing rental properties. The general partners, who typically hold 1% of the partnership interests, are third parties unrelated to the Company and its affiliates, and are responsible for controlling and managing the business and financial operations of the partnerships. As a limited partner, the Company is not responsible for any of the liabilities and obligations of the partnerships nor do the partnerships or their creditors have any recourse to the Company other than for the capital requirements. All available tax benefits from low-income housing tax credits provided by the partnerships were claimed as of fiscal year 2012. The risk that previously claimed low-income housing tax credits might be recaptured or otherwise retroactively invalidated is considered remote.

INCOME_TAXES

INCOME TAXES	12 Months Ended
	Jun. 30, 2014
INCOME TAXES [Abstract]	'
INCOME TAXES	'
	NOTE 18. INCOME TAXES
	The provision for income taxes on continuing operations, by tax jurisdiction, consisted of the following as of June 30:
			2014				2013			2012
	Current
	Federal		$	247			$	245		$	197
	State			34				23			12
	Foreign			45				19			45
	Total current			326				287			254
	Deferred
	Federal			(19	)			(1	)		(4	)
	State			2				(2	)		1
	Foreign			(4	)			(5	)		(8	)
	Total deferred			(21	)			(8	)		(11	)
	Total		$	305			$	279		$	243
	The components of earnings from continuing operations before income taxes, by tax jurisdiction, consisted of the following as of
	June 30:
				2014				2013			2012
	United States			$	754			$	724		$	649
	Foreign				130				128			129
	Total			$	884			$	852		$	778
	A reconciliation of the statutory federal income tax rate to the Company's effective tax rate on continuing operations follows as of June 30:
		2014			2013			2012
	Statutory federal tax rate	35	%		35	%		35	%
	State taxes (net of federal tax benefits)	2.6			1.7			1.1
	Tax differential on foreign earnings	(0.3	)		(2.9	)		(2.0	)
	Domestic manufacturing deduction	(2.3	)		(2.3	)		(2.3	)
	Change in Valuation Allowance	0.6			0.7			0.8
	Other differences	(1.0	)		0.5			(1.3	)
	Effective tax rate	34.6	%		32.7	%		31.3	%
	The lower effective tax rate for fiscal year 2013 compared to fiscal year 2014 was primarily due to favorable tax settlements and lower taxes on foreign earnings.
	Applicable U.S. income taxes and foreign withholding taxes have not been provided on approximately $186 of undistributed earnings of certain foreign subsidiaries as of June 30, 2014, because these earnings are considered indefinitely reinvested. The net federal income tax liability that could arise if these earnings were not indefinitely reinvested is approximately $50. Applicable U.S. income and foreign withholding taxes are provided on these earnings in the periods in which they are no longer considered indefinitely reinvested.
	Tax benefits resulting from stock-based payment arrangements that are in excess of the tax benefits recorded in net earnings over the vesting period of those arrangements (excess tax benefits) are recorded as increases to additional paid-in capital. Excess tax benefits of approximately $11, $11, and $10, were realized and recorded to additional paid-in capital for the fiscal years 2014, 2013 and 2012, respectively.
	The components of deferred tax assets (liabilities) as of June 30 are shown below:
		2014				2013
	Deferred tax assets
	Compensation and benefit programs	$	171			$	176
	Basis difference related to Venture Agreement		30				30
	Accruals and reserves		53				55
	Inventory costs		20				20
	Net operating loss and tax credit carryforwards		37				33
	Other		63				51
	Subtotal		374				365
	Valuation allowance		(51	)			(36	)
	Total deferred tax assets		323				329
	Deferred tax liabilities
	Fixed and intangible assets		(269	)			(273	)
	Low-income housing partnerships		(24	)			(23	)
	Unremitted foreign earnings		(8	)			(18	)
	Other		(26	)			(24	)
	Total deferred tax liabilities		(327	)			(338	)
	Net deferred tax liabilities	$	(4	)		$	(9	)
	The Company periodically reviews its deferred tax assets for recoverability. A valuation allowance is established when the Company believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Valuation allowances have been provided to reduce deferred tax assets to amounts considered recoverable. Details of the valuation allowance were as follows as of June 30:
		2014					2013
	Valuation allowance at beginning of year	$	(36	)			$	(20	)
	Net decrease in realizability of foreign deferred tax assets		(12	)				(9	)
	Net increase in foreign net operating loss carryforward and other		(3	)				(7	)
	Valuation allowance at end of year	$	(51	)			$	(36	)
	As of June 30, 2014, the Company had foreign tax credit carryforwards of $19 for U.S. income tax purposes. Tax credit carryforwards in foreign jurisdictions of $14 have expiration dates in fiscal year 2016. Tax benefits from foreign net operating loss carryforwards of $19 have expiration dates between fiscal years 2016 and 2025. Tax benefits from foreign net operating loss carryforwards of $4 may be carried forward indefinitely.
	The Company files income tax returns in the U.S. federal and various state, local and foreign jurisdictions. The federal statute of limitations has expired for all tax years through June 30, 2010. Various income tax returns in state and foreign jurisdictions are currently in the process of examination.
	Certain issues relating to fiscal years 1996 through 2000 were effectively settled by the Company and the Canadian Revenue Agency in the first quarter of fiscal year 2012, resulting in a net benefit of tax and interest of $7. No tax benefits had previously been recognized for these issues in the Company's consolidated financial statements.
	The Company recognizes interest and penalties related to uncertain tax positions as a component of income tax expense. As of June 30, 2014 and 2013, the total balance of accrued interest and penalties related to uncertain tax positions was $11 and $8, respectively. Interest and penalties included in income tax expense resulted in a net expense of $3, a net expense of $1, and a net benefit of $3 in fiscal years 2014, 2013 and 2012, respectively. The following is a reconciliation of the beginning and ending amounts of the Company's gross unrecognized tax benefits:
			2014				2013			2012
	Unrecognized tax benefits - July 1		$	69			$	80		$	97
Gross increases - tax positions in prior periods			3				3			4
Gross decreases - tax positions in prior periods			(5	)			(19	)		(17	)
Gross increases - current period tax positions			7				7			5
Gross decreases -  current period tax positions			-				-			(1	)
Lapse of applicable statute of limitations			(1	)			(2	)		(2	)
Settlements			(2	)			-			(6	)
Unrecognized tax benefits - June 30		$	71			$	69		$	80
Included in the balance of unrecognized tax benefits as of June 30, 2014, 2013 and 2012, are potential benefits of $58, $56 and $56, respectively, which if recognized, would affect the effective tax rate on earnings.
In the twelve months succeeding June 30, 2014, it is reasonably possible that up to $30 of other unrecognized tax benefits may be recognized. Audit outcomes and the timing of audit settlements are subject to significant uncertainty.

EMPLOYEE_BENEFIT_PLANS

EMPLOYEE BENEFIT PLANS	12 Months Ended
	Jun. 30, 2014
EMPLOYEE BENEFIT PLANS [Abstract]	'
EMPLOYEE BENEFIT PLANS	'
	NOTE 19. EMPLOYEE BENEFIT PLANS
	Retirement Income Plans
	Effective July 1, 2011, and as part of a set of long-term, cost-neutral enhancements to the Company's overall employee benefit plans, the domestic qualified plan was frozen for service accrual and eligibility purposes for most participants, however, interest credits have continued to accrue on participant balances. As of June 30, 2014 and 2013, the benefits of the domestic qualified plan are based on either employee years of service and compensation or a stated dollar amount per years of service. The Company is the sole contributor to the plan in amounts deemed necessary to provide benefits and to the extent deductible for federal income tax purposes. Assets of the plan consist primarily of investments in cash equivalents, mutual funds and common collective trusts. The Company did not make any contributions to its domestic qualified retirement income plan during fiscal years 2014, 2013 and 2012. The Company's funding policy for its qualified plans is to contribute amounts sufficient to meet minimum funding requirements as set forth in employee benefit tax laws plus additional amounts as the Company may determine to be appropriate.
	Contributions made to the domestic nonqualified retirement income plans were $13, $11 and $11 in fiscal years 2014, 2013 and 2012, respectively. Contributions made to the foreign retirement income plans were $2, $1 and $1 in fiscal years 2014, 2013 and 2012, respectively.
	Retirement Health Care
	The Company provides certain health care benefits for employees who meet age, participation and length of service requirements at retirement. The plans pay stated percentages of covered expenses after annual deductibles have been met or stated reimbursements up to a specified dollar subsidy amount. Benefits paid take into consideration payments by Medicare for the domestic plan. The plans are funded as claims are paid, and the Company has the right to modify or terminate certain plans.
	The assumed domestic health care cost trend rate used in measuring the accumulated postretirement benefit obligation was 7.3% for medical and 7.7% for prescription drugs for fiscal year 2014. These rates have been assumed to gradually decrease each year until an assumed ultimate trend of 4.5% is reached in 2028. The health care cost trend rate assumption has an effect on the amounts reported. The effect of a hypothetical 100 basis point increase or decrease in the assumed domestic health care cost trend rate on the total service and interest cost components, and the postretirement benefit obligation would have been $0, $0 and $1 for the fiscal years ended June 30, 2014, 2013 and 2012, respectively.
	Financial Information Related to Retirement Income and Retirement Health Care
	Summarized information for the Company's retirement income and retirement health care plans at and for the fiscal years ended June 30 is as follows:
		Retirement								Retirement
		Income								Health Care
		2014				2013				2014				2013
	Change in benefit obligations:
	Projected benefit obligation at beginning of year	$	612			$	646			$	51			$	63
	Service cost		3				4				1				1
	Interest cost		27				24				2				2
	Actuarial (gain) loss		47				(27	)			(2	)			(9	)
	Plan amendments		-				-				(2	)			(5	)
	Translation and other adjustment		(6	)			-				-				-
	Benefits paid		(42	)			(35	)			(1	)			(1	)
	Projected benefit obligation at end of year		641				612				49				51
	Change in plan assets:
	Fair value of assets at beginning of year		408				394				-				-
	Actual return on plan assets		51				37				-				-
	Employer contributions to nonqualified plans		15				12				1				1
	Benefits paid		(42	)			(35	)			(1	)			(1	)
	Fair value of plan assets at end of year		432				408				-				-
	Accrued benefit cost, net funded status	$	(209	)		$	(204	)		$	(49	)		$	(51	)
	Amount recognized in the balance sheets consists of:
	Pension benefit assets	$	2			$	-			$	-			$	-
	Current accrued benefit liability	$	(14	)		$	(17	)		$	(4	)		$	(4	)
	Non-current accrued benefit liability		(197	)			(187	)			(45	)			(47	)
	Accrued benefit cost, net	$	(209	)		$	(204	)		$	(49	)		$	(51	)
	Retirement income plans with an accumulated benefit obligation (ABO) in excess of plan assets as of June 30 were as follows:
			Pension Plans								Other
											Retirement Plans
			2014				2013				2014				2013
	Projected benefit obligation		$	538			$	529			$	78			$	80
	Accumulated benefit obligation			538				528				78				80
	Fair value of plan assets			405				405				-				-
	The ABO for all pension plans was $563, $530 and $561 as of June 30, 2014, 2013 and 2012, respectively. The ABO for all retirement income plans increased by $31 in fiscal year 2014, primarily due to a decrease in the discount rate assumption.
	The net costs of the retirement income and health care plans for the fiscal years ended June 30 included the following components:
		Retirement Income												Retirement Health Care
		2014				2013				2012				2014			2013			2012
	Service cost	$	3			$	4			$	-			$	1		$	1		$	1
	Interest cost		27				24				29				2			2			3
	Expected return on plan assets		(25	)			(29	)			(31	)			-			-			-
	Amortization of unrecognized items		11				12				8				(4	)		(2	)		(3	)
	Total	$	16			$	11			$	6			$	(1	)	$	1		$	1
	Items not yet recognized as a component of postretirement expense as of June 30, 2014, consisted of:
		Retirement				Retirement
		Income				Health Care
	Net actuarial loss (gain)	$	247			$	(29	)
	Prior service cost (benefit)		1				(9	)
	Net deferred income tax (assets) liabilities		(92	)			14
	Accumulated other comprehensive loss (income)	$	156			$	(24	)
	Net actuarial loss (gain) recorded in accumulated other comprehensive net losses for the fiscal year ended June 30, 2014, included the following:
		Retirement				Retirement
		Income				Health Care
	Net actuarial loss (gain) at beginning of year	$	239			$	(29	)
	Amortization during the year		(11	)			2
	Loss (gain) during the year		19				(2	)
	Net actuarial loss (gain) at end of year	$	247			$	(29	)
The Company uses the straight-line amortization method for unrecognized prior service costs and benefits. In fiscal year 2015, the Company expects to recognize, on a pre-tax basis, approximately less than $1 of the prior service cost and $11 of the net actuarial loss as a component of net periodic benefit cost for the retirement income plans, and approximately $1 of the prior service credit and $3 of the net actuarial gain as a component of net periodic benefit cost for the retirement health care plans.
Weighted-average assumptions used to estimate the actuarial present value of benefit obligations as of June 30 were as follows:
	Retirement Income						Retirement Health Care
	2014			2013			2014			2013
Discount rate	4.05	%		4.39	%		4	%		4.33	%
Rate of compensation increase	4.46	%		3.44	%		n/a			n/a
Weighted-average assumptions used to estimate the net periodic pension and other postretirement benefit costs as of June 30 were as follows:
	Retirement Income
	2014			2013			2012
Discount rate	4.39	%		3.87	%		5.31	%
Rate of compensation increase	3.44	%		3.71	%		3.93	%
Expected return on plan assets	6.61	%		7.5	%		8.12	%
	Retirement Health Care
	2014			2013			2012
Discount rate	4.33	%		3.86	%		5.29	%
The expected long-term rate of return assumption is based on an analysis of historical experience of the portfolio and the summation of prospective returns for each asset class in proportion to the fund's current asset allocation.
Expected benefit payments for the Company's pension and other postretirement plans as of June 30, 2014, were as follows:
		Retirement				Retirement
		Income				Health Care
2015		$	38			$	4
2016			39				4
2017			40				3
2018			41				3
2019			39				3
Fiscal years 2020 through 2024			196				13
Expected benefit payments are based on the same assumptions used to measure the benefit obligations and include estimated future employee service.
The target allocations and weighted average asset allocations by asset category of the investment portfolio for the Company's domestic retirement income plans as of June 30 were:
	% Target Allocation						% of Plan Assets
	2014			2013			2014			2013
U.S. equity	11	%		20	%		11	%		20	%
International equity	12			21			12			21
Fixed income	74			54			74			54
Other	3			5			3			5
Total	100	%		100	%		100	%		100	%
The target asset allocation is determined based on the optimal balance between risk and return and, at times, may be adjusted to achieve the plan's overall investment objective to generate sufficient resources to pay current and projected plan obligations over the life of the domestic qualified retirement income plan.
The following table sets forth by level within the fair value hierarchy, the retirement income plans' assets carried at fair value as of June 30:
			2014
			Level 1				Level 2				Total
Cash equivalents			$	3			$	-			$	3
Common collective trusts
Bond funds				-				309				309
International equity funds				-				64				64
Domestic equity funds				-				44				44
Real Estate fund				-				12				12
Total common collective trusts				-				429				429
Total assets at fair value			$	3			$	429			$	432
			2013
				Level 1				Level 2				Total
Cash equivalents			$	3			$	-			$	3
Common collective trusts
Bond funds				-				217				217
International equity funds				-				93				93
Domestic equity funds				-				77				77
Real Estate fund				-				18				18
Total common collective trusts				-				405				405
Total assets at fair value			$	3			$	405			$	408
The carrying value of cash equivalents approximates its fair value as of June 30, 2014 and 2013.
Common collective trust funds are not publicly traded and, therefore, are classified as Level 2. They are valued at a net asset value unit price determined by the portfolio's sponsor based on the fair value of underlying assets held by the common collective trust fund on June 30, 2014 and 2013.
The common collective trusts are invested in various trusts that attempt to achieve their investment objectives by investing primarily in other collective investment funds which have characteristics consistent with each trust's overall investment objective and strategy.
Defined Contribution Plans
The Company has defined contribution plans for most of its domestic employees. The plans include The Clorox Company 401(k) Plan, The Clorox Company 2011 Nonqualified Defined Benefit Plan and the Executive Retirement Plan. The aggregate cost of the domestic defined contribution plans was $43, $45 and $50 in fiscal years 2014, 2013 and 2012, respectively. Included in the aggregate cost was the cost of The Clorox Company 401(k) Plan of $38, $40 and $46 in fiscal years 2014, 2013 and 2012, respectively. The Company also has defined contribution plans for certain international employees. The aggregate cost of these foreign plans was $3, $1 and $1 for the fiscal years ended June 30, 2014, 2013 and 2012, respectively.

SEGMENT_REPORTING

SEGMENT REPORTING	12 Months Ended
	Jun. 30, 2014
SEGMENT REPORTING [Abstract]	'
SEGMENT REPORTING	'
	NOTE 20. SEGMENT REPORTING
	The Company operates through strategic business units that are aggregated into four reportable segments: Cleaning, Household, Lifestyle and International.
	Cleaning consists of laundry, home care and professional products marketed and sold in the United States. Products within this segment include laundry additives, including bleach products under the Clorox® brand and Clorox 2® stain fighter and color booster; home care products, primarily under the Clorox®, Formula 409®, Liquid-Plumr®, Pine-Sol®, S.O.S® and Tilex® brands; naturally derived products under the Green Works® brand; and professional cleaning and disinfecting products under the Clorox®, Dispatch®, Aplicare®, HealthLink® and Clorox Healthcare® brands.
	Household consists of charcoal, cat litter and plastic bags, wraps and container products marketed and sold in the United States. Products within this segment include plastic bags, wraps and containers under the Glad® brand; cat litter products under the Fresh Step®, Scoop Away® and Ever Clean® brands; and charcoal products under the Kingsford® and Match Light® brands.
	Lifestyle consists of food products, water-filtration systems and filters, and natural personal care products marketed and sold in the United States. Products within this segment include dressings and sauces, primarily under the Hidden Valley®, KC Masterpiece® and Soy Vay® brands; water-filtration systems and filters under the Brita® brand; and natural personal care products under the Burt's Bees® brand.
	International consists of products sold outside the United States. Products within this segment include laundry, home care, water-filtration, charcoal and cat litter products, dressings and sauces, plastic bags, wraps and containers and natural personal care products, primarily under the Clorox®, Javex®, Glad®, PinoLuz®, Ayudin®, Limpido®, Clorinda®, Poett®, Mistolin®, Lestoil®, Bon Bril®,  Brita®, Green Works®, Pine-Sol®, Agua Jane®, Chux®, Kingsford®, Fresh Step®, Scoop Away®, Ever Clean®, KC Masterpiece®, Hidden Valley® and Burt's Bees® brands.
	Certain non-allocated administrative costs, interest income, interest expense and various other non-operating income and expenses are reflected in Corporate. Corporate assets include cash and cash equivalents, property and equipment, other investments and deferred taxes.
	Argentina
	The operating environment in Argentina presents business challenges, including price controls on some of the Company's products, a devaluing currency and inflation. For the fiscal years ended June 30, 2014, 2013 and 2012, the value of the Argentine peso (ARS) per USD declined 34%, 16% and 9%, respectively. In addition, in July 2014, the Argentine government defaulted on debt payment agreements. As of June 30, 2014, using an exchange rate of 8.1 ARS per USD, the Company's Argentina subsidiary had total assets of $105, including cash and cash equivalents of $25, net receivables of $20, inventories of $15, net property, plant and equipment of $20 and intangible assets excluding goodwill of $5. Goodwill for Argentina is aggregated and assessed for impairment at the Latin America reporting unit level, which is a component of the Company's International segment. Based on the results of the annual impairment test performed in the fourth quarter of fiscal year 2014, the fair value of the Latin America reporting unit exceeded its recorded value by more than 40%. Net sales from the Company's Argentina subsidiary represented approximately 3%, 4% and 3% of the Company's consolidated net sales for each of the fiscal years ended June 30, 2014, 2013 and 2012, respectively. The Company is closely monitoring developments in Argentina and is taking steps intended to mitigate the adverse conditions.
		Fiscal	Cleaning		Household		Lifestyle		International		Corporate			Total
		Year												Company
	Net sales	2014	$	1,776	$	1,709	$	936	$	1,093	$	-		$	5,514
		2013		1,783		1,693		929		1,128		-			5,533
		2012		1,692		1,676		901		1,110		-			5,379
	Earnings (losses) from continuing
	operations before income taxes	2014		428		326		258		99		(227	)		884
		2013		420		336		259		95		(258	)		852
		2012		381		298		265		106		(272	)		778
	(Losses) earnings from discontinued
	operations, net of tax	2014		-		-		-		-21		-			(21	)
		2013		-		-		-		-1		-			(1	)
		2012		-		-		-		6		-			6
	Income from equity investees	2014		-		-		-		13		-			13
		2013		-		-		-		12		-			12
		2012		-		-		-		11		-			11
	Total assets	2014		887		745		869		1,190		567			4,258
		2013		905		799		878		1,202		527			4,311
	Capital expenditures	2014		37		53		11		31		5			137
		2013		57		72		19		24		18			190
		2012		63		79		18		29		-			189
	Depreciation and amortization	2014		49		67		19		25		17			177
		2013		52		69		19		26		14			180
		2012		45		73		18		24		17			177
	Significant noncash charges included
	in earnings (losses) from continuing
	operations before income taxes:
	Share-based compensation	2014		11		9		5		1		10			36
		2013		10		9		5		1		10			35
		2012		13		12		6		1		(5	)		27
	All intersegment sales are eliminated and are not included in the Company's reportable segments' net sales.
	Net sales to the Company's largest customer, Walmart Stores, Inc. and its affiliates, were 27% of consolidated net sales for each of the fiscal years ended 2014, 2013 and 2012, and occurred in each of the Company's reportable segments. No other customers accounted for more than 10% of consolidated net sales in any of these fiscal years. During fiscal years 2014, 2013 and 2012, the Company's five largest customers accounted for 45% of its net sales.
	The Company has three product lines that have accounted for 10% or more of consolidated net sales during each of the past three fiscal years. In fiscal years 2014, 2013 and 2012, sales of liquid bleach represented approximately 13%, 14% and 14% of the Company's consolidated net sales, respectively, approximately 26%, 26% and 26% of net sales in the Cleaning segment, respectively, and approximately 28%, 28% and 27% of net sales in the International segment, respectively. Sales of trash bags represented approximately 13% of the Company's consolidated net sales in each of the fiscal years 2014, 2013 and 2012, approximately 36%, 37% and 35% of net sales in the Household segment and approximately 8%, 10% and 10% of net sales in the International segment, respectively. Sales of charcoal represented approximately 11%, 10% and 11% of the Company's consolidated net sales and approximately 34%, 32% and 35% of net sales in the Household segment in fiscal years 2014, 2013 and 2012, respectively.
	Net sales and property, plant and equipment, net, by geographic area as of and for the fiscal years ended June 30 were as follows:
		Fiscal	United		Foreign		Total
		Year	States				Company
	Net sales	2014	$	4,466	$	1,048	$	5,514
		2013		4,448		1,085		5,533
		2012		4,316		1,063		5,379
	Property, plant and equipment, net	2014	$	825	$	152	$	977
		2013		860		161		1,021

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Jun. 30, 2014
RELATED PARTY TRANSACTIONS [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	NOTE 21. RELATED PARTY TRANSACTIONS
	The Company holds various equity investments with ownership percentages of up to 50% in a number of consumer products businesses, most of which operate outside the United States. The Company has no ongoing capital commitments, loan requirements, guarantees or any other types of arrangements under the terms of its agreements that would require any future cash contributions or disbursements arising out of an equity investment.
	Transactions with the Company's equity investees typically represent payments for contract manufacturing and purchases of raw materials. Payments to related parties, including equity investees, for such transactions during the fiscal years ended June 30, 2014, 2013 and 2012 were $57, $50 and $49, respectively. Receipts from and ending accounts receivable and payable balances related to the Company's related parties were not significant during and as of the end of each of the fiscal years presented.

UNAUDITED_QUARTERLY_DATA

UNAUDITED QUARTERLY DATA	12 Months Ended
	Jun. 30, 2014
UNAUDITED QUARTERLY DATA [Abstract]	'
UNAUDITED QUARTERLY DATA	'
	NOTE 22. UNAUDITED QUARTERLY DATA
		Quarters Ended
		September 30			31-Dec			31-Mar			30-Jun			Total Year
	Fiscal year ended June 30, 2014
	Net sales	$	1,343		$	1,308		$	1,366		$	1,497		$	5,514
	Cost of products sold	$	759		$	753		$	791		$	855		$	3,158
	Earnings from continuing operations	$	139		$	118		$	151		$	171		$	579
	Losses from discontinued operations,
	net of tax	$	(3	)	$	(3	)	$	(14	)	$	(1	)	$	(21	)
	Net earnings	$	136		$	115		$	137		$	170		$	558
	Per common share:
	Basic
	Continuing operations	$	1.07		$	0.91		$	1.16		$	1.32		$	4.47
	Discontinued operations		(0.03	)		(0.02	)		(0.11	)		-			(0.16	)
	Basic net earnings per share	$	1.04		$	0.89		$	1.05		$	1.32		$	4.31
	Diluted
	Continuing operations	$	1.05		$	0.9		$	1.14		$	1.3		$	4.39
	Discontinued operations		(0.02	)		(0.03	)		(0.10	)		(0.01	)		(0.16	)
	Diluted net earnings per share	$	1.03		$	0.87		$	1.04		$	1.29		$	4.23
	Dividends declared per common share	$	0.71		$	0.71		$	0.71		$	0.74		$	2.87
	Market price (NYSE)
	High	$	87.6		$	96.76		$	92.75		$	93.43		$	96.76
	Low		81.25			80.2			83.7			86.56			80.2
	Year-end														91.4
	Fiscal year ended June 30, 2013
	Net sales	$	1,314		$	1,302		$	1,392		$	1,525		$	5,533
	Cost of products sold	$	746		$	743		$	802		$	851		$	3,142
	Earnings from continuing operations	$	132		$	124		$	135		$	182		$	573
	Earnings (losses) from discontinued operations,
	net of tax	$	1		$	(1	)	$	(2	)	$	1		$	(1	)
	Net earnings	$	133		$	123		$	133		$	183		$	572
	Per common share:
	Basic
	Continuing operations	$	1.01		$	0.95		$	1.02		$	1.39		$	4.37
	Discontinued operations		0.01			(0.01	)		(0.01	)		-			-
	Basic net earnings per share	$	1.02		$	0.94		$	1.01		$	1.39		$	4.37
	Diluted
	Continuing operations	$	1		$	0.94		$	1.01		$	1.37		$	4.31
	Discontinued operations		0.01			(0.01	)		(0.01	)		-			(0.01	)
	Diluted net earnings per share	$	1.01		$	0.93		$	1		$	1.37		$	4.3
	Dividends declared per common share	$	0.64		$	0.64		$	0.64		$	0.71		$	2.63
	Market price (NYSE)
	High	$	73.65		$	76.74		$	88.63		$	90.1		$	90.1
	Low		69.67			71			73.5			81.12			69.67
	Year-end														83.14

VALUATION_AND_QUALIFYING_ACCOU

VALUATION AND QUALIFYING ACCOUNTS AND RESERVES	12 Months Ended
	Jun. 30, 2014
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES [Abstract]	'
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES	'
	VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Dollars in millions)
	Column A	Column B			Column C			Column D				Column E
					Additions			Deductions
	Description	Balance at			Charged to			Credited to		Credited		Balance at
		beginning			costs and			costs and		to other		end
		of period			expenses			expenses		accounts		of period
	Allowance for doubtful accounts
	Year ended June 30, 2014	$	(5	)	$	-		$	2	$	-	$	(3	)
	Year ended June 30, 2013		(7	)		-			2		-		(5	)
	Year ended June 30, 2012		(5	)		(3	)		1		-		(7	)
	LIFO allowance
	Year ended June 30, 2014	$	(40	)	$	-		$	3	$	1	$	(36	)
	Year ended June 30, 2013		(37	)		(3	)		-		-		(40	)
	Year ended June 30, 2012		(29	)		(8	)		-		-		(37	)
	Valuation allowance on deferred tax assets
	Year ended June 30, 2014	$	(36	)	$	(25	)	$	-	$	10	$	(51	)
	Year ended June 30, 2013		(20	)		(16	)		-		-		(36	)
	Year ended June 30, 2012		(14	)		(6	)		-		-		(20	)
	Allowance for inventory obsolescence
	Year ended June 30, 2014	$	(11	)	$	(13	)	$	-	$	10	$	(14	)
	Year ended June 30, 2013		(10	)		(12	)		-		11		(11	)
	Year ended June 30, 2012		(11	)		(13	)		-		14		(10	)

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policy)	12 Months Ended
	Jun. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUTING POLICIES [Abstract]	'
Nature of Operations and Basis of Presentation	'
	Nature of Operations and Basis of Presentation
	The Company is principally engaged in the production, marketing and sales of consumer products through mass retail outlets, e-commerce channels, distributors and medical supply providers. The consolidated financial statements include the statements of the Company and its wholly owned and controlled subsidiaries. All significant intercompany transactions and accounts were eliminated in consolidation. Certain prior year reclassifications were made in the consolidated financial statements and related notes to the consolidated financial statements to conform to the current year presentation.
	As discussed more fully under Note 2 – Discontinued Operations, the Company's Venezuela affiliate, Corporación Clorox de Venezuela S.A. (Clorox Venezuela), a component of the International reportable segment, discontinued its operations effective September 22, 2014. Since this exit occurred subsequent to the filing of the Company's Annual Report on Form 10-K for the year ended June 30, 2014, the Company has reclassified the financial results of Clorox Venezuela as a discontinued operation in the consolidated financial statements for all periods presented herein.
Use of Estimates	'
	Use of Estimates
	The preparation of these consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect reported amounts and related disclosures. Specific areas requiring the application of management's estimates and judgments include assumptions pertaining to accruals for consumer and trade-promotion programs, stock-based compensation costs, pension and post-employment benefit costs, future cash flows associated with impairment testing of goodwill and other long-lived assets, the credit worthiness of customers, uncertain tax positions, tax valuation allowances and legal, environmental and insurance matters. Actual results could materially differ from estimates and assumptions made.
Recently Issued Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements
	In May 2014, the Financial Accounting Standards Board (FASB) issued an update to current accounting standards, which establishes a single, comprehensive revenue recognition model for all contracts with customers, and will supersede most current revenue recognition guidance. It requires entities to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments are effective for the Company beginning in the first quarter of fiscal year 2018. Early adoption is not permitted. The Company is currently in the process of evaluating the impact of the adoption of these requirements on its consolidated financial statements.
	In April 2014, the FASB issued an update to current accounting standards, which will change the criteria for reporting discontinued operations. The amendments will also require new disclosures about discontinued operations and disposals of components of an entity that do not qualify for discontinued operations reporting. The amendments are effective for the Company for new disposals (or classifications as held for sale) of components of the Company, should they occur, beginning in the first quarter of fiscal year 2016. Early adoption is permitted for disposals (or classifications as held for sale) that have not been previously reported. The Company does not expect the adoption of the new standard to materially impact its reporting of Clorox Venezuela.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	Cash equivalents consist of highly liquid instruments, time deposits and money market funds with an initial maturity at purchase of three months or less. The fair value of cash and cash equivalents approximates the carrying amount.
	The Company's cash position includes amounts held by foreign subsidiaries and, as a result, the repatriation of certain cash balances from some of the Company's foreign subsidiaries could result in additional tax costs. However, these cash balances are generally available without legal restriction to fund local business operations. In addition, a portion of the Company's cash balance is held in U.S. dollars by foreign subsidiaries, whose functional currency is their local currency. Such U.S. dollar balances are reported on the foreign subsidiaries' books, in their functional currency, with the impact from foreign currency exchange rate differences recorded in other income, net. The Company's cash holdings were as follows as of June 30:
			2014		2013
	U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent		$	180	$	130
	Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries			132		115
	U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries			12		36
	Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries			5		18
	Total		$	329	$	299
Inventories	'
	Inventories
	Inventories are stated at the lower of cost or market. When necessary, the Company provides allowances to adjust the carrying value of its inventory to the lower of cost or market, including any costs to sell or dispose. Appropriate consideration is given to obsolescence, excessive inventory levels, product deterioration and other factors in evaluating net realizable value for the purposes of determining the lower of cost or market.
Property, Plant and Equipment and Finite-Lived Intangible Assets	'
	Property, Plant and Equipment and Finite-Lived Intangible Assets
	Property, plant and equipment and finite-lived intangible assets are stated at cost. Depreciation and amortization expense are calculated by the straight-line method using the estimated useful lives or lives determined by lease contracts of the related assets. The table below provides estimated useful lives of property, plant and equipment by asset classification.
		Estimated
		Useful Lives
	Buildings and leasehold improvements	10 - 40 years
	Land improvements	10 - 30 years
	Machinery and equipment	3 - 15 years
	Computer equipment	3 - 5 years
	Capitalized software costs	3 - 7 years
	Property, plant and equipment and finite-lived intangible assets are reviewed for impairment whenever events or changes in circumstances occur that indicate that the carrying amount of an asset (or asset group) may not be fully recoverable. The risk of impairment is initially assessed based on an estimate of the undiscounted cash flows at the lowest level for which identifiable cash flows exist. Impairment occurs when the book value of the asset exceeds the estimated future undiscounted cash flows generated by the asset and the impairment is viewed as other than temporary. When an impairment is indicated, an impairment charge is recorded for the difference between the book value of the asset and its estimated fair market value. Depending on the asset, estimated fair market value may be determined either by use of a discounted cash flow model or by reference to estimated selling values of assets in similar condition.
Capitalization of Software Costs	'
	Capitalization of Software Costs
	The Company capitalizes certain significant costs incurred in the acquisition and development of software for internal use, including the costs of the software, materials, consultants, interest and payroll and payroll-related costs for employees during the application development stage. Costs incurred prior to the application development stage, costs incurred once the application is substantially complete and ready for its intended use and other costs not qualifying for capitalization, including training and maintenance costs, are charged to expense. Capitalized software amortization expense was $22, $21 and $18, in fiscal years 2014, 2013 and 2012, respectively.
Impairment Review of Goodwill and Indefinite-Lived Intangible Assets	'
	Impairment Review of Goodwill and Indefinite-Lived Intangible Assets
	The Company tests its goodwill, trademarks with indefinite lives and other indefinite-lived intangible assets annually for impairment in the fiscal fourth quarter unless there are indications during a different interim period that these assets may have become impaired. With respect to goodwill, the Company performs either a qualitative or quantitative evaluation for each of its reporting units. Factors considered in the qualitative test include maturity and stability of the reporting unit, magnitude of excess fair value over book value from past year's impairment testing, other reporting unit specific operating results as well as new events and circumstances impacting the operations at the reporting unit level. If the result of a qualitative test indicates a potential for impairment of a reporting unit, a quantitative test is performed. The quantitative test is a two-step process. In the first step, the Company compares the estimated fair value of the reporting unit to its carrying value. If the estimated fair value of any reporting unit is less than its carrying value, the Company performs a second step to determine the implied fair value of the reporting unit's goodwill. If the carrying amount of a reporting unit's goodwill exceeds its implied fair value, an impairment charge is recorded for the difference between the carrying amount and the implied fair value of the reporting unit's goodwill. For trademarks and other intangible assets with indefinite lives, the Company performs a quantitative analysis to test for impairment and compares the estimated fair value of an asset to its carrying amount. If the carrying amount of such asset exceeds its estimated fair value, an impairment charge is recorded for the difference between the carrying amount and the estimated fair value. The Company's estimates of fair value are based primarily on a discounted cash flow or income approach that requires significant management judgment with respect to future sales volumes, revenue and expense growth rates, changes in working capital, foreign exchange rates, currency devaluation, inflation and a perpetuity growth rate.
Stock-based Compensation	'
	Stock-based Compensation
	The Company grants various nonqualified stock-based compensation awards to eligible employees, including stock options and performance units.
	For stock options, the Company estimates the fair value of each award on the date of grant using the Black-Scholes valuation model, which requires management to make estimates regarding expected option life, stock price volatility and other assumptions. Groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. The Company estimates stock option forfeitures based on historical data for each employee grouping. The total number of stock options expected to vest is adjusted by actual and estimated forfeitures. Changes to the actual and estimated forfeitures will result in a cumulative catch-up adjustment in the period of change. Compensation expense is recorded by amortizing the grant date fair values on a straight-line basis over the vesting period, adjusted for estimated forfeitures.
	The Company's performance unit grants provide for the issuance of common stock to certain managerial staff and executive management if the Company achieves specified performance targets. The performance period is three years and the payout determination is made at the end of the three-year performance period. The fair value of each grant issued is estimated on the date of grant based on the current market price of the stock. The total amount of compensation expense recognized reflects estimated forfeiture rates and the initial assumption that performance goals will be achieved. Compensation expense is adjusted based on management's assessment of the probability that performance goals will be achieved. If such goals are not met or it is determined that achievement of performance goals is not probable, previously recognized compensation expense is trued up in the current period to reflect the expected payout level. If it is determined that the performance goals will be exceeded, additional compensation expense is recognized, subject to a cap of 150% of target.
	Cash flows resulting from tax deductions in excess of the cumulative compensation cost recognized for stock-based payment arrangements (excess tax benefits) are classified as financing cash inflows.
Employee Benefits	'
	Employee Benefits
	The Company accounts for its defined benefit retirement income and retirement health care plans using actuarial methods. These methods use an attribution approach that generally spreads “plan events” over the service lives or expected lifetime (for frozen plans) of plan participants. Examples of plan events are plan amendments and changes in actuarial assumptions such as the expected return on plan assets, discount rate, rate of compensation increase and certain employee-related factors, such as retirement age and mortality. The principle underlying the attribution approach is that employees render service over their employment period on a relatively “smooth” basis and, therefore, the statement of earnings effects of retirement income and retirement health care plans are recognized in the same pattern.
	One of the principal assumptions used in the net periodic benefit cost calculation is the expected return on plan assets. The required use of an expected return on plan assets may result in recognized pension expense or income that differs from the actual returns of those plan assets in any given year. Over time, however, the goal is for the expected long-term returns to approximate the actual returns and, therefore, the expectation is that the pattern of income and expense recognition should closely match the pattern of the services provided by the participants. The Company uses a market-related value method for calculating plan assets for purposes of determining the amortization of actuarial gains and losses. This method employs an asset smoothing approach. The differences between actual and expected returns are recognized in the net periodic benefit cost calculation over the average remaining service period or expected lifetime (for frozen plans) of the plan participants using the corridor approach. Under this approach, only actuarial gains (losses) that exceed 5% of the greater of the projected benefit obligation or the market-related value of assets are amortized to pension expense by the Company. In developing its expected return on plan assets, the Company considers the long-term actual returns relative to the mix of investments that comprise its plan assets and also develops estimates of future investment returns by considering external sources.
	The Company recognizes an actuarial-based obligation at the onset of disability for certain benefits provided to individuals after employment, but before retirement, that include medical, dental, vision, life and other benefits.
Environmental Costs	'
	Environmental Costs
	The Company is involved in certain environmental remediation and ongoing compliance activities. Accruals for environmental matters are recorded on a site-by-site basis when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. The Company's accruals reflect the anticipated participation of other potentially responsible parties in those instances where it is probable that such parties are legally responsible and financially capable of paying their respective shares of the relevant costs. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Actual costs to be incurred at identified sites in future periods may vary from the estimates, given the inherent uncertainties in evaluating environmental exposures. The aggregate accrual for environmental matters is included in other liabilities in the Company's consolidated balance sheets on an undiscounted basis due to uncertainty regarding the timing of future payments.
Revenue Recognition	'
	Revenue Recognition
	Sales are recognized as revenue when the risk of loss and title pass to the customer and when all of the following have occurred: a firm sales arrangement exists, pricing is fixed or determinable and collection is reasonably assured. Sales are recorded net of allowances for returns, trade promotions, coupons and other discounts. The Company routinely commits to one-time or ongoing trade-promotion programs with customers and consumer coupon programs that require the Company to estimate and accrue the expected costs of such programs. Programs include shelf price reductions, end-of-aisle or in-store displays of the Company's products and graphics and other trade-promotion activities conducted by the customer. Coupons are recognized as a liability when distributed based upon expected consumer redemptions. The Company maintains liabilities related to these programs for the estimated expenses incurred, but not paid, at the end of each period. Trade-promotion and coupon redemption costs are recorded as a reduction of sales. The Company provides an allowance for doubtful accounts based on its historical experience and ongoing assessment of its customers' credit risk. Receivables were presented net of an allowance for doubtful accounts of $3 and $5 as of June 30, 2014 and 2013, respectively. The Company's provision for doubtful accounts was $0, $0 and $3 in fiscal years 2014, 2013 and 2012, respectively.
	Receivables, net, included non-customer receivables of $15 and $13 as of June 30, 2014 and 2013, respectively.
Cost of Products Sold	'
	Cost of Products Sold
	Cost of products sold represents the costs directly related to the manufacture and distribution of the Company's products and primarily includes raw materials, packaging, contract packer fees, shipping and handling, warehousing, package design, depreciation, amortization, direct and indirect labor and operating costs for the Company's manufacturing and distribution facilities including salary, benefit costs and incentive compensation, and royalties and amortization related to the Company's Glad Venture Agreement (see Note 11 – Other Liabilities).
	Costs associated with developing and designing new packaging are expensed as incurred and include design, artwork, films and labeling. Expenses for fiscal years ended June 30, 2014, 2013 and 2012 were $12, $10 and $10, respectively, all of which were reflected in cost of products sold or discontinued operations, as appropriate, in the consolidated statements of earnings.
Selling and Administrative Expenses	'
	Selling and Administrative Expenses
	Selling and administrative expenses represent costs incurred by the Company in generating revenues and managing the business and include market research, commissions and certain administrative expenses. Administrative expenses include salary, benefits, incentive compensation, professional fees and services, software and licensing fees and other operating costs associated with the Company's non-manufacturing, non-research and development staff, facilities and equipment.
Advertising and Research and Development Costs	'
	Advertising and Research and Development Costs
	The Company expenses advertising and research and development costs in the period incurred.
Income Taxes	'
	Income Taxes
	The Company uses the asset and liability method to account for income taxes. Deferred tax assets and liabilities are recognized for the anticipated future tax consequences attributable to differences between financial statement amounts and their respective tax bases. Management reviews the Company's deferred tax assets to determine whether their value can be realized based upon available evidence. A valuation allowance is established when management believes that it is more likely than not that some portion of its deferred tax assets will not be realized. Changes in valuation allowances from period to period are included in the Company's tax provision in the period of change. In addition to valuation allowances, the Company provides for uncertain tax positions when such tax positions do not meet certain recognition thresholds or measurement standards. Amounts for uncertain tax positions are adjusted in quarters when new information becomes available or when positions are effectively settled.
	U.S. income tax expense and foreign withholding taxes are provided on unremitted foreign earnings that are not indefinitely reinvested at the time the earnings are generated. Where foreign earnings are indefinitely reinvested, no provision for U.S. income or foreign withholding taxes is made. When circumstances change and the Company determines that some or all of the undistributed earnings will be remitted in the foreseeable future, the Company accrues an expense in the current period for U.S. income taxes and foreign withholding taxes attributable to the anticipated remittance.
Foreign Currency Transactions and Translation	'
	Foreign Currency Transactions and Translation
	Local currencies are the functional currencies for substantially all of the Company's foreign operations. When the transactional currency is different than the functional currency, transaction gains and losses are included as a component of other income, net. In addition, certain assets and liabilities denominated in currencies different than a foreign subsidiary's functional currency are reported on the subsidiary's books in its functional currency, with the impact from exchange rate differences recorded in other income, net. Except for Clorox Venezuela as discussed below and in Note 2 – Discontinued Operations, assets and liabilities of foreign operations are translated into U.S. dollars using the exchange rates in effect at the balance sheet date, while income and expenses are translated at the average monthly exchange rates during the year.
	Gains and losses on foreign currency translations are reported as a component of other comprehensive income. Deferred taxes are not provided on cumulative translation adjustments where the Company expects earnings of a foreign subsidiary to be indefinitely reinvested. The income tax effect of currency translation adjustments related to foreign subsidiaries and joint ventures for which earnings are not considered indefinitely reinvested is recorded as a component of deferred taxes with an offset to other comprehensive income.
	Due to a sustained inflationary environment, the financial statements of Clorox Venezuela are consolidated under the rules governing the preparation of financial statements in a highly inflationary economy. As such, Clorox Venezuela's non-U.S. dollar (non-USD) denominated monetary assets and liabilities are remeasured into U.S. dollars (USD) each reporting period with the resulting gains and losses reflected in (losses) earnings from discontinued operations, net.
Derivative Instruments	'
	Derivative Instruments
	The Company's use of derivative instruments, principally swaps, futures and forward contracts, is limited to non-trading purposes and is designed to partially manage exposure to changes in commodity prices, interest rates and foreign currencies. The Company's contracts are hedges for transactions with notional amounts and periods consistent with the related exposures and do not constitute investments independent of these exposures.
	Most commodity, interest rate and foreign exchange derivative contracts are designated as cash flow hedges of certain forecasted raw material purchases, interest payments and finished goods inventory purchases, based on certain hedge criteria. The criteria used to determine if hedge accounting treatment is appropriate are: (a) whether the designation of the hedge is to an underlying exposure and (b) whether there is sufficient correlation between the value of the derivative instrument and the underlying obligation. The changes in the fair value of derivatives are recorded as either assets or liabilities in the balance sheet with an offset to net earnings or other comprehensive income depending on whether, for accounting purposes, the derivative is designated and qualifies as a hedge. The Company de-designates cash flow hedge relationships when it determines that the hedge relationships are no longer highly effective or that the forecasted transaction is no longer probable. Upon de-designation of a hedge, the portion of gains or losses on the derivative instrument that was previously accumulated in other comprehensive income remains in accumulated other comprehensive income until the forecasted transaction is recognized in net earnings, or is recognized in net earnings immediately if the forecasted transaction is no longer probable. From time to time, the Company may have contracts not designated as hedges for accounting purposes, for which it recognizes changes in the fair value in other income, net. Cash flows from hedging activities are classified as operating activities in the consolidated statements of cash flows.
	The Company uses different methodologies, when necessary, to estimate the fair value of its derivative contracts. The estimated fair values of the majority of the Company's contracts are based on quoted market prices, traded exchange market prices, or broker price quotations, and represent the estimated amounts that the Company would pay or receive to terminate the contracts.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Jun. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUTING POLICIES [Abstract]	'
Components of Cash and Cash Equivalents	'
			2014		2013
	U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent		$	180	$	130
	Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries			132		115
	U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries			12		36
	Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries			5		18
	Total		$	329	$	299
Useful Lives of Property, Plant and Equipment	'
		Estimated
		Useful Lives
	Buildings and leasehold improvements	10 - 40 years
	Land improvements	10 - 30 years
	Machinery and equipment	3 - 15 years
	Computer equipment	3 - 5 years
	Capitalized software costs	3 - 7 years

DISCONTINUED_OPERATIONS_Tables

DISCONTINUED OPERATIONS (Tables)	12 Months Ended
	Jun. 30, 2014
DISCONTINUED OPERATIONS	'
Summary of net sales and breakdown of losses from discontinued operations	'
		2014			2013			2012
	Net sales for Clorox Venezuela	$	77		$	90		$	89
	Operating (losses) earnings from Clorox Venezuela before income taxes		(23	)		1			13
	Income tax benefit (expense) attributable to Clorox Venezuela		6			-			(5	)
	Operating (losses) earnings from Clorox Venezuela, net of tax		(17	)		1			8
	Losses from other discontinued operations, net of tax		(4	)		(2	)		(2	)
	(Losses) earnings from discontinued operations, net of tax	$	(21	)	$	(1	)	$	6

INVENTORIES_NET_Tables

INVENTORIES, NET (Tables)	12 Months Ended
	Jun. 30, 2014
INVENTORIES, NET [Abstract]	'
Schedule of Inventories, Net	'
		2014			2013
	Finished goods	$	321		$	321
	Raw materials and packaging		113			121
	Work in process		2			3
	LIFO allowances		(36	)		(40	)
	Allowances for obsolescence		(14	)		(11	)
	Total	$	386		$	394

OTHER_CURRENT_ASSETS_Tables

OTHER CURRENT ASSETS (Tables)	12 Months Ended
	Jun. 30, 2014
OTHER CURRENT ASSETS [Abstract]	'
Other Current Assets	'
		2014		2013
	Deferred tax assets	$	81	$	87
	Prepaid expenses		42		41
	Other		11		19
	Total	$	134	$	147

PROPERTY_PLANT_AND_EQUIPMENT_N1

PROPERTY, PLANT AND EQUIPMENT, NET (Tables)	12 Months Ended
	Jun. 30, 2014
PROPERTY, PLANT AND EQUIPMENT, NET [Abstract]	'
Schedule of Property, Plant and Equipment, Net	'
		2014			2013
	Machinery and equipment	$	1,593		$	1,590
	Buildings		506			485
	Capitalized software costs		374			362
	Land and improvements		122			119
	Construction in progress		79			96
	Computer equipment		79			80
			2,753			2,732
	Less: accumulated depreciation and amortization		(1,776	)		(1,711	)
	Total	$	977		$	1,021

GOODWILL_TRADEMARKS_AND_OTHER_1

GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Tables)	12 Months Ended
	Jun. 30, 2014
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS [Abstract]	'
Schedule of Goodwill	'
			Goodwill
			Cleaning			Lifestyle			Household			International					Total
	Balance June 30, 2012		$	323		$	244		$	85		$	460				$	1,112
	Translation adjustments and other			-			-			-			(7	)				(7	)
	Balance June 30, 2013		$	323		$	244		$	85		$	453				$	1,105
	Translation adjustments and other			-			-			-			(4	)				(4	)
	Balance June 30, 2014		$	323		$	244		$	85		$	449				$	1,101
Schedule of Intangible Assets, Excluding Goodwill	'
		Trademarks									Other intangible assets
		Subject to			Not subject to			Total			Technology				Other				Total
		amortization			amortization						and product
											formulae
	Balance June 30, 2012	$	19		$	537		$	556		$	23			$	63			$	86
	Amortization		(3	)		-			(3	)		(9	)			(6	)			(15	)
	Translation adjustments and other		-			-			-			5				(2	)			3
	Balance June 30, 2013	$	16		$	537		$	553		$	19			$	55			$	74
	Acquisitions and other additions		-			-			-			-				5				5
	Amortization		(1	)		-			(1	)		(9	)			(6	)			(15	)
	Impairment		-			(4	)		(4	)		-				-				-
	Translation adjustments and other		(1	)		-			(1	)		-				-				-
	Balance June 30, 2014	$	14		$	533		$	547		$	10			$	54			$	64

ACCRUED_LIABILITIES_Tables

ACCRUED LIABILITIES (Tables)	12 Months Ended
	Jun. 30, 2014
ACCRUED LIABILITIES [Abstract]	'
Accrued Liabilities	'
		2014		2013
	Trade and sales promotion	$	113	$	116
	Compensation and employee benefit costs		102		152
	Dividends		100		96
	Interest		27		27
	Insurance		18		20
	Derivatives		17		3
	Royalties		11		11
	Other		84		65
	Total	$	472	$	490

DEBT_Tables

DEBT (Tables)	12 Months Ended
	Jun. 30, 2014
DEBT [Abstract]	'
Short-term Notes and Loans Payable	'
			2014			2013
	Commercial paper		$	141		$	200
	Foreign borrowings			2			2
	Total		$	143		$	202
Long-Term Debt, Net of Unamortized Discounts or Premiums	'
		2014			2013
	Senior unsecured notes and debentures:
	5.00%, $575 due January 2015	$	575		$	575
	3.55%, $300 due November 2015		300			300
	5.95%, $400 due October 2017		399			399
	3.80%, $300 due November 2021		298			298
	3.05%, $600 due September 2022		598			598
	Total		2,170			2,170
	Less: Current maturities of long-term debt		(575	)		-
	Long-term debt	$	1,595		$	2,170
Borrowing Capacity Under Other Financing Arrangements	'
			2014			2013
	Revolving credit facility		$	1,100		$	1,100
	Foreign credit lines			31			32
	Other credit lines			13			13
	Total		$	1,144		$	1,145

FINANCIAL_INSTRUMENTS_AND_FAIR1

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Jun. 30, 2014
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]	'
Schedule of Financial Instruments Measured at Fair Value	'
					2014								2013
		Balance sheet
		classification			Level 1				Level 2				Level 1				Level 2
	Assets
	Foreign exchange derivative contracts	Other current assets			$	-			$	-			$	-			$	4
	Commodity purchase derivative contracts	Other current assets				-				1				-				-
	Trust assets for nonqualified deferred
	compensation plans	Other assets				31				-				-				-
					$	31			$	1			$	-			$	4
	Liabilities
	Commodity purchase derivative contracts	Accrued liabilities			$	-			$	1			$	-			$	3
	Interest rate derivative contracts	Accrued liabilities				-				13				-				-
	Foreign exchange derivative contracts	Accrued liabilities				-				3				-				-
					$	-			$	17			$	-			$	3
Effects of Derivative Financial Instruments Designated as Hedging Instruments on OCI and on Consolidated Statement of Earnings	'
			Gains (losses) recognized in OCI												Gains (losses) reclassified from OCI
															and recognized in earnings
			2014				2013				2012				2014				2013			2012
	Commodity purchase derivative contracts		$	2			$	(1	)		$	(1	)		$	-			$	-		$	4
	Interest rate derivative contracts			(13	)			(1	)			(39	)			(4	)			(3	)		(2	)
	Foreign exchange derivative contracts			(3	)			3				3				4				-			2
	Total		$	(14	)		$	1			$	(37	)		$	-			$	(3	)	$	4

OTHER_LIABILITIES_Tables

OTHER LIABILITIES (Tables)	12 Months Ended
	Jun. 30, 2014
OTHER LIABILITIES [Abstract]	'
Other Liabilities	'
		2014		2013
	Venture agreement net terminal obligation	$	290	$	284
	Employee benefit obligations		289		270
	Taxes		76		74
	Other		113		114
	Total	$	768	$	742

STOCKHOLDERS_EQUITY_Tables

STOCKHOLDERS' EQUITY (Tables)	12 Months Ended
	Jun. 30, 2014
STOCKHOLDERS' EQUITY [Abstract]	'
Schedule of Share Repurchases under Authorized Programs	'
		2014							2013							2012
		Amount			Shares				Amount			Shares				Amount		Shares
					0							0						0
	Open-market purchase programs	$	-			-			$	-			-			$	158		2,429
	Evergreen Program		260			3,046				128			1,500				67		990
	Total	$	260			3,046			$	128			1,500			$	225		3,419
Schedule of Accumulated Other Comprehensive Net Losses	'
		Foreign				Net unrealized				Pension and				Total
		currency				(losses) gains on				postretirement
		translation				derivatives				benefit
		adjustments								adjustments
	Balance as of June 30, 2012, net of tax	$	(198	)		$	(33	)		$	(165	)		$	(396	)
	Other comprehensive (loss) income
	before reclassifications		(11	)			-				31				20
	Amounts reclassified from accumulated other
	comprehensive net losses		-				3				6				9
	Net other comprehensive (loss) income		(11	)			3				37				29
	Balance as of June 30, 2013, net of tax	$	(209	)		$	(30	)		$	(128	)		$	(367	)
	Other comprehensive losses
	before reclassifications		(37	)			(9	)			(9	)			(55	)
	Amounts reclassified from accumulated other
	comprehensive net losses		-				-				5				5
	Net other comprehensive losses		(37	)			(9	)			(4	)			(50	)
	Balance as of June 30, 2014, net of tax	$	(246	)		$	(39	)		$	(132	)		$	(417	)

NET_EARNINGS_PER_SHARE_EPS_Tab

NET EARNINGS PER SHARE (EPS) (Tables)	12 Months Ended
	Jun. 30, 2014
NET EARNINGS PER SHARE (EPS) [Abstract]	'
Schedule of Weighted Average Number of Shares Outstanding	'
		2014	2013	2012
	Basic	129,558	131,075	130,852
	Dilutive effect of stock options and other	2,184	1,894	1,458
	Diluted	131,742	132,969	132,310

STOCKBASED_COMPENSATION_PLANS_

STOCK-BASED COMPENSATION PLANS (Tables)	12 Months Ended
	Jun. 30, 2014
STOCK-BASED COMPENSATION PLANS [Abstract]	'
Schedule of Stock-based Compensation	'
				2014			2013			2012
	Cost of products sold			$	4		$	4		$	3
	Selling and administrative expenses				29			28			22
	Research and development costs				3			3			2
	Total compensation cost			$	36		$	35		$	27
	Related income tax benefit			$	13		$	13		$	10
Schedule of Stock Option Valuation Assumptions	'
			2014				2013				2012
	Expected life			5.7 years				5.7 years				4.9 - 5.7 years
	Weighted-average expected life			5.7 years				5.7 years				5.7 years
	Expected volatility			18.4% to 18.5%				18.7% to 19.2%				21.9% to 25.9%
	Weighted-average volatility			18.50%				19.10%				23.50%
	Risk-free interest rate			1.8% to 1.9%				0.6% to 0.8%				0.9% to 1.1%
	Weighted-average risk-free interest rate			1.80%				0.70%				0.90%
	Dividend yield			3.40%				3.2%-3.6%				3.5%-3.8%
	Weighted-average dividend yield			3.40%				3.60%				3.50%
Summary of Stock Option Activity	'
			Number of				Weighted-		Average				Aggregate
			Shares				Average		Remaining				Intrinsic
							Exercise		Contractual				Value
							Price		Life
							per Share
			(In thousands)
	Options outstanding as of June 30, 2013			10,257			$	65		7 years			$	184
	Granted			1,795				84
	Exercised			(1,450	)			60
	Cancelled			(234	)			75
	Options outstanding as of June 30, 2014			10,368			$	69		6 years			$	232
	Options vested as of June 30, 2014			5,772			$	64		5 years			$	159
Summary of Restricted Stock Award Activity	'
		Number of			Weighted-Average
		Shares			Grant Date
					Fair Value
					per Share
		(In thousands)
	Restricted stock awards as of June 30, 2013	11			$	68
	Granted	13				89
	Vested	(3	)			67
	Forfeited	-				-
	Restricted stock awards as of June 30, 2014	21			$	81
Summary of Performance Units Award Activity	'
		Number of			Weighted-Average
		Shares			Grant Date
					Fair Value
					per Share
		(In thousands)
	Performance unit awards as of June 30, 2013	1,335			$	66
	Granted	347				84
	Distributed	(35	)			54
	Forfeited	(426	)			67
	Performance unit awards as of June 30, 2014	1,221			$	73
	Perfomance units vested and deferred as of June 30, 2014	168			$	56

OTHER_INCOME_NET_Tables

OTHER INCOME, NET (Tables)	12 Months Ended
	Jun. 30, 2014
OTHER INCOME, NET [Abstract]	'
Major Components of Other Income, Net	'
		2014		2013		2012
	Income from equity investees	$	-13	$	-12	$	-11
	Insurance and other settlements		-5		-		-
	Interest income		-3		-3		-3
	Income from transition and related services		-1		-3		-6
	Amortization of trademarks and other intangible assets (Note 7)		8		9		9
	Intangible asset impairment charges (Note 7)		3		-		-
	Foreign exchange transaction losses, net (Note 1)		1		8		1
	Low-income housing partnership gains and other, net		-		-3		-2
	Total	$	-10	$	-4	$	-12

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
	Jun. 30, 2014
INCOME TAXES [Abstract]	'
Provision for Income Taxes on Continuing Operations by Tax Jurisdiction	'
			2014				2013			2012
	Current
	Federal		$	247			$	245		$	197
	State			34				23			12
	Foreign			45				19			45
	Total current			326				287			254
	Deferred
	Federal			(19	)			(1	)		(4	)
	State			2				(2	)		1
	Foreign			(4	)			(5	)		(8	)
	Total deferred			(21	)			(8	)		(11	)
	Total		$	305			$	279		$	243
Earnings from Continuing Operations before Income Taxes, by Tax Jurisdiction	'
				2014				2013			2012
	United States			$	754			$	724		$	649
	Foreign				130				128			129
	Total			$	884			$	852		$	778
Effective Income Tax Rate Reconciliation	'
		2014			2013			2012
	Statutory federal tax rate	35	%		35	%		35	%
	State taxes (net of federal tax benefits)	2.6			1.7			1.1
	Tax differential on foreign earnings	(0.3	)		(2.9	)		(2.0	)
	Domestic manufacturing deduction	(2.3	)		(2.3	)		(2.3	)
	Change in Valuation Allowance	0.6			0.7			0.8
	Other differences	(1.0	)		0.5			(1.3	)
	Effective tax rate	34.6	%		32.7	%		31.3	%
Current and Noncurrent Deferred Tax Assets and Liabilities	'
		2014				2013
	Deferred tax assets
	Compensation and benefit programs	$	171			$	176
	Basis difference related to Venture Agreement		30				30
	Accruals and reserves		53				55
	Inventory costs		20				20
	Net operating loss and tax credit carryforwards		37				33
	Other		63				51
	Subtotal		374				365
	Valuation allowance		(51	)			(36	)
	Total deferred tax assets		323				329
	Deferred tax liabilities
	Fixed and intangible assets		(269	)			(273	)
	Low-income housing partnerships		(24	)			(23	)
	Unremitted foreign earnings		(8	)			(18	)
	Other		(26	)			(24	)
	Total deferred tax liabilities		(327	)			(338	)
	Net deferred tax liabilities	$	(4	)		$	(9	)
Summary of Deferred Tax Asset Valuation Allowance	'
		2014					2013
	Valuation allowance at beginning of year	$	(36	)			$	(20	)
	Net decrease in realizability of foreign deferred tax assets		(12	)				(9	)
	Net increase in foreign net operating loss carryforward and other		(3	)				(7	)
	Valuation allowance at end of year	$	(51	)			$	(36	)
Reconciliation of Gross Unrecognized Tax Benefits	'
			2014				2013			2012
	Unrecognized tax benefits - July 1		$	69			$	80		$	97
	Gross increases - tax positions in prior periods			3				3			4
	Gross decreases - tax positions in prior periods			(5	)			(19	)		(17	)
	Gross increases - current period tax positions			7				7			5
	Gross decreases -  current period tax positions			-				-			(1	)
	Lapse of applicable statute of limitations			(1	)			(2	)		(2	)
	Settlements			(2	)			-			(6	)
	Unrecognized tax benefits - June 30		$	71			$	69		$	80

EMPLOYEE_BENEFIT_PLANS_Tables

EMPLOYEE BENEFIT PLANS (Tables)	12 Months Ended
	Jun. 30, 2014
EMPLOYEE BENEFIT PLANS [Abstract]	'
Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan	'
		Retirement								Retirement
		Income								Health Care
		2014				2013				2014				2013
	Change in benefit obligations:
	Projected benefit obligation at beginning of year	$	612			$	646			$	51			$	63
	Service cost		3				4				1				1
	Interest cost		27				24				2				2
	Actuarial (gain) loss		47				(27	)			(2	)			(9	)
	Plan amendments		-				-				(2	)			(5	)
	Translation and other adjustment		(6	)			-				-				-
	Benefits paid		(42	)			(35	)			(1	)			(1	)
	Projected benefit obligation at end of year		641				612				49				51
	Change in plan assets:
	Fair value of assets at beginning of year		408				394				-				-
	Actual return on plan assets		51				37				-				-
	Employer contributions to nonqualified plans		15				12				1				1
	Benefits paid		(42	)			(35	)			(1	)			(1	)
	Fair value of plan assets at end of year		432				408				-				-
	Accrued benefit cost, net funded status	$	(209	)		$	(204	)		$	(49	)		$	(51	)
Schedule of Amounts Recognized in the Balance Sheets	'
		Retirement								Retirement
		Income								Health Care
		2014				2013				2014				2013
	Amount recognized in the balance sheets consists of:
	Pension benefit assets	$	2			$	-			$	-			$	-
	Current accrued benefit liability	$	(14	)		$	(17	)		$	(4	)		$	(4	)
	Non-current accrued benefit liability		(197	)			(187	)			(45	)			(47	)
	Accrued benefit cost, net	$	(209	)		$	(204	)		$	(49	)		$	(51	)
Schedule of Accumulated Benefit Obligations in Excess of Plan Assets	'
			Pension Plans								Other
											Retirement Plans
			2014				2013				2014				2013
	Projected benefit obligation		$	538			$	529			$	78			$	80
	Accumulated benefit obligation			538				528				78				80
	Fair value of plan assets			405				405				-				-
Schedule of Components of Net Periodic Benefit Cost	'
		Retirement Income												Retirement Health Care
		2014				2013				2012				2014			2013			2012
	Service cost	$	3			$	4			$	-			$	1		$	1		$	1
	Interest cost		27				24				29				2			2			3
	Expected return on plan assets		(25	)			(29	)			(31	)			-			-			-
	Amortization of unrecognized items		11				12				8				(4	)		(2	)		(3	)
	Total	$	16			$	11			$	6			$	(1	)	$	1		$	1
Schedule of Items Not Yet Recognized as a Component of Postretirement Expense	'
		Retirement				Retirement
		Income				Health Care
	Net actuarial loss (gain)	$	247			$	(29	)
	Prior service cost (benefit)		1				(9	)
	Net deferred income tax (assets) liabilities		(92	)			14
	Accumulated other comprehensive loss (income)	$	156			$	(24	)
Summary of Amounts Recognized in Accumulated Other Comprehensive Net Losses	'
		Retirement				Retirement
		Income				Health Care
	Net actuarial loss (gain) at beginning of year	$	239			$	(29	)
	Amortization during the year		(11	)			2
	Loss (gain) during the year		19				(2	)
	Net actuarial loss (gain) at end of year	$	247			$	(29	)
Schedule of Weighted Average Assumptions Used	'
		Retirement Income						Retirement Health Care
		2014			2013			2014			2013
	Discount rate	4.05	%		4.39	%		4	%		4.33	%
	Rate of compensation increase	4.46	%		3.44	%		n/a			n/a
		Retirement Income
		2014			2013			2012
	Discount rate	4.39	%		3.87	%		5.31	%
	Rate of compensation increase	3.44	%		3.71	%		3.93	%
	Expected return on plan assets	6.61	%		7.5	%		8.12	%
		Retirement Health Care
		2014			2013			2012
	Discount rate	4.33	%		3.86	%		5.29	%
Schedule of Expected Benefit Payments	'
			Retirement				Retirement
			Income				Health Care
	2015		$	38			$	4
	2016			39				4
	2017			40				3
	2018			41				3
	2019			39				3
	Fiscal years 2020 through 2024			196				13
Schedule of Target Weighted Average Asset Allocations	'
		% Target Allocation						% of Plan Assets
		2014			2013			2014			2013
	U.S. equity	11	%		20	%		11	%		20	%
	International equity	12			21			12			21
	Fixed income	74			54			74			54
	Other	3			5			3			5
	Total	100	%		100	%		100	%		100	%
Schedule of Plan Assets Carried at Fair Value	'
				2014
				Level 1				Level 2				Total
	Cash equivalents			$	3			$	-			$	3
	Common collective trusts
	Bond funds				-				309				309
	International equity funds				-				64				64
	Domestic equity funds				-				44				44
	Real Estate fund				-				12				12
	Total common collective trusts				-				429				429
	Total assets at fair value			$	3			$	429			$	432
				2013
					Level 1				Level 2				Total
	Cash equivalents			$	3			$	-			$	3
	Common collective trusts
	Bond funds				-				217				217
	International equity funds				-				93				93
	Domestic equity funds				-				77				77
	Real Estate fund				-				18				18
	Total common collective trusts				-				405				405
	Total assets at fair value			$	3			$	405			$	408

SEGMENT_REPORTING_Tables

SEGMENT REPORTING (Tables)	12 Months Ended
	Jun. 30, 2014
SEGMENT REPORTING [Abstract]	'
Selected Financial Information Relating to the Company's Segments	'
		Fiscal	Cleaning		Household		Lifestyle		International		Corporate			Total
		Year												Company
	Net sales	2014	$	1,776	$	1,709	$	936	$	1,093	$	-		$	5,514
		2013		1,783		1,693		929		1,128		-			5,533
		2012		1,692		1,676		901		1,110		-			5,379
	Earnings (losses) from continuing
	operations before income taxes	2014		428		326		258		99		(227	)		884
		2013		420		336		259		95		(258	)		852
		2012		381		298		265		106		(272	)		778
	(Losses) earnings from discontinued
	operations, net of tax	2014		-		-		-		-21		-			(21	)
		2013		-		-		-		-1		-			(1	)
		2012		-		-		-		6		-			6
	Income from equity investees	2014		-		-		-		13		-			13
		2013		-		-		-		12		-			12
		2012		-		-		-		11		-			11
	Total assets	2014		887		745		869		1,190		567			4,258
		2013		905		799		878		1,202		527			4,311
	Capital expenditures	2014		37		53		11		31		5			137
		2013		57		72		19		24		18			190
		2012		63		79		18		29		-			189
	Depreciation and amortization	2014		49		67		19		25		17			177
		2013		52		69		19		26		14			180
		2012		45		73		18		24		17			177
	Significant noncash charges included
	in earnings (losses) from continuing
	operations before income taxes:
	Share-based compensation	2014		11		9		5		1		10			36
		2013		10		9		5		1		10			35
		2012		13		12		6		1		(5	)		27
Net Sales and Long-Lived Assets By Geographic Area	'
		Fiscal	United		Foreign		Total
		Year	States				Company
	Net sales	2014	$	4,466	$	1,048	$	5,514
		2013		4,448		1,085		5,533
		2012		4,316		1,063		5,379
	Property, plant and equipment, net	2014	$	825	$	152	$	977
		2013		860		161		1,021

UNAUDITED_QUARTERLY_DATA_Table

UNAUDITED QUARTERLY DATA (Tables)	12 Months Ended
	Jun. 30, 2014
UNAUDITED QUARTERLY DATA [Abstract]	'
Unaudited Quarterly Data	'
		Quarters Ended
		September 30			31-Dec			31-Mar			30-Jun			Total Year
	Fiscal year ended June 30, 2014
	Net sales	$	1,343		$	1,308		$	1,366		$	1,497		$	5,514
	Cost of products sold	$	759		$	753		$	791		$	855		$	3,158
	Earnings from continuing operations	$	139		$	118		$	151		$	171		$	579
	Losses from discontinued operations,
	net of tax	$	(3	)	$	(3	)	$	(14	)	$	(1	)	$	(21	)
	Net earnings	$	136		$	115		$	137		$	170		$	558
	Per common share:
	Basic
	Continuing operations	$	1.07		$	0.91		$	1.16		$	1.32		$	4.47
	Discontinued operations		(0.03	)		(0.02	)		(0.11	)		-			(0.16	)
	Basic net earnings per share	$	1.04		$	0.89		$	1.05		$	1.32		$	4.31
	Diluted
	Continuing operations	$	1.05		$	0.9		$	1.14		$	1.3		$	4.39
	Discontinued operations		(0.02	)		(0.03	)		(0.10	)		(0.01	)		(0.16	)
	Diluted net earnings per share	$	1.03		$	0.87		$	1.04		$	1.29		$	4.23
	Dividends declared per common share	$	0.71		$	0.71		$	0.71		$	0.74		$	2.87
	Market price (NYSE)
	High	$	87.6		$	96.76		$	92.75		$	93.43		$	96.76
	Low		81.25			80.2			83.7			86.56			80.2
	Year-end														91.4
	Fiscal year ended June 30, 2013
	Net sales	$	1,314		$	1,302		$	1,392		$	1,525		$	5,533
	Cost of products sold	$	746		$	743		$	802		$	851		$	3,142
	Earnings from continuing operations	$	132		$	124		$	135		$	182		$	573
	Earnings (losses) from discontinued operations,
	net of tax	$	1		$	(1	)	$	(2	)	$	1		$	(1	)
	Net earnings	$	133		$	123		$	133		$	183		$	572
	Per common share:
	Basic
	Continuing operations	$	1.01		$	0.95		$	1.02		$	1.39		$	4.37
	Discontinued operations		0.01			(0.01	)		(0.01	)		-			-
	Basic net earnings per share	$	1.02		$	0.94		$	1.01		$	1.39		$	4.37
	Diluted
	Continuing operations	$	1		$	0.94		$	1.01		$	1.37		$	4.31
	Discontinued operations		0.01			(0.01	)		(0.01	)		-			(0.01	)
	Diluted net earnings per share	$	1.01		$	0.93		$	1		$	1.37		$	4.3
	Dividends declared per common share	$	0.64		$	0.64		$	0.64		$	0.71		$	2.63
	Market price (NYSE)
	High	$	73.65		$	76.74		$	88.63		$	90.1		$	90.1
	Low		69.67			71			73.5			81.12			69.67
	Year-end														83.14

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Cash Holdings) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011
In Millions, unless otherwise specified
SUMMARY OF SIGNIFICANT ACCOUTING POLICIES [Abstract]	'	'	'	'
U.S. dollar balances held by U.S. dollar functional currency subsidiaries and at parent	$180	$130	'	'
Non-U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries	132	115	'	'
U.S. dollar balances held by non-U.S. dollar functional currency subsidiaries	12	36	'	'
Non-U.S. dollar balances held by U.S. dollar functional currency subsidiaries	5	18	'	'
Total	$329	$299	$267	$259

SUMMARY_OF_SIGNIFICANT_ACCOUNT4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Estimated Useful Lives of Property, Plant and Equipment) (Details)	12 Months Ended
	Jun. 30, 2014
Buildings and leasehold improvements [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'10 years
Buildings and leasehold improvements [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'40 years
Land improvements [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'10 years
Land improvements [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'30 years
Machinery and equipment [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'3 years
Machinery and equipment [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'15 years
Computer equipment [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'3 years
Computer equipment [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'5 years
Capitalized software costs [Member] | Minimum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'3 years
Capitalized software costs [Member] | Maximum [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated Useful Lives	'7 years

SUMMARY_OF_SIGNIFICANT_ACCOUNT5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Additional Information) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
SUMMARY OF SIGNIFICANT ACCOUTING POLICIES [Abstract]	'	'	'
Capitalized software amortization	$22	$21	$18
Performance period for performance awards	'3 years	'	'
Additional compensation expense, target cap	150.00%	'	'
Minimum actuarial gains amortized to pension expense	5.00%	'	'
Allowance for doubtful accounts, net of tax	3	5	'
Provision for doubtful accounts	0	0	3
Non-customer receivables	15	13	'
New packaging development and design costs	12	10	10
New packaging development and design costs in cost of products sold	$12	$10	$10

DISCONTINUED_OPERATIONS_Detail

DISCONTINUED OPERATIONS (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Discontinued operations	'	'	'	'	'	'	'	'	'	'	'
Operating (losses) earnings from discontinued operations, net of tax	($1)	($14)	($3)	($3)	$1	($2)	($1)	$1	($21)	($1)	$6
Clorox Venezuela [Member]	'	'	'	'	'	'	'	'	'	'	'
Discontinued operations	'	'	'	'	'	'	'	'	'	'	'
Net sales for Clorox Venezuela	'	'	'	'	'	'	'	'	77	90	89
Operating (losses) earnings from discontinued operations before income taxes	'	'	'	'	'	'	'	'	-23	1	13
Income tax benefit (expense) attributable to discontinued operations	'	'	'	'	'	'	'	'	6	0	-5
Operating (losses) earnings from discontinued operations, net of tax	'	'	'	'	'	'	'	'	-17	1	8
Other Discontinued Operations [Member]	'	'	'	'	'	'	'	'	'	'	'
Discontinued operations	'	'	'	'	'	'	'	'	'	'	'
Operating (losses) earnings from discontinued operations, net of tax	'	'	'	'	'	'	'	'	($4)	($2)	($2)

DISCONTINUED_OPERATIONS_Hyperi

DISCONTINUED OPERATIONS (Hyperinflation and the Selection of Exchange Rates) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Mar. 01, 2014	Feb. 08, 2013
Latin America [Member]	'	'	'
Discontinued operations	'	'	'
Percentage of fair value of the reporting unit in excess of recorded value	40.00%	'	'
Venezuelan Subsidiary [Member]	'	'	'
Discontinued operations	'	'	'
Exchange rate per USD	'	'	6.3
Exchange rate per USD before devaluation	'	'	4.3
Venezuelan eliminated currency exchange system (SITME)	'	'	5.7
Venezuelan fixed currency exchange system (CENCOEX)	'	6.3	6.3
Venezuelan floating currency exchange system (SICAD I)	10.6	'	'
Venezuelan second floating currency exchange system (SICAD II)	50	'	'
Remeasurement loss	$10	'	'
Total Assets of business	68	'	'
Cash and cash equivalents of business	5	'	'
Long-term value added tax (VAT) receivable	9	'	'
Inventory of business	11	'	'
Net property, plant and equipment of business	16	'	'
Intangible assets excluding goodwill	$6	'	'

BUSINESSES_ACQUIRED_Details

BUSINESSES ACQUIRED (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
BUSINESSES ACQUIRED [Abstract]	'	'	'
Aggregate purchase price	'	'	$97
Amount paid for acquisition	$0	$0	$93

INVENTORIES_NET_Details

INVENTORIES, NET (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
INVENTORIES, NET [Abstract]	'	'	'
Finished goods	$321	$321	'
Raw materials and packaging	113	121	'
Work in process	2	3	'
LIFO allowances	-36	-40	'
Allowances for obsolescence	-14	-11	'
Total	386	394	'
Percentage of inventory valued with the LIFO method	34.00%	37.00%	'
Effect on earnings of the liquidation of LIFO layers	2	3	2
Inventory consigned to others	4	2	'
Obsolescence expense	$13	$12	$13

OTHER_CURRENT_ASSETS_Details

OTHER CURRENT ASSETS (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified
OTHER CURRENT ASSETS [Abstract]	'	'
Deferred tax assets	$81	$87
Prepaid expenses	42	41
Other	11	19
Total	134	147
Restricted Cash and Cash Equivalents Items [Line Items]	'	'
Restricted cash	9	13
Foreign subsidiary, prepayment for intercompany services [Member]	'	'
Restricted Cash and Cash Equivalents Items [Line Items]	'	'
Restricted cash	5	10
Escrow [Member]	'	'
Restricted Cash and Cash Equivalents Items [Line Items]	'	'
Restricted cash	$3	$3

PROPERTY_PLANT_AND_EQUIPMENT_N2

PROPERTY, PLANT AND EQUIPMENT, NET (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
PROPERTY, PLANT AND EQUIPMENT, NET [Abstract]	'	'	'
Depreciation and amortization expense related to property, plant and equipment, net	$161	$162	$158
Property, Plant and Equipment [Line Items]	'	'	'
Property, plant and equipment	2,753	2,732	'
Less: accumulated depreciation and amortization	-1,776	-1,711	'
Total	977	1,021	'
Machinery and equipment [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, plant and equipment	1,593	1,590	'
Buildings [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, plant and equipment	506	485	'
Capitalized software costs [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, plant and equipment	374	362	'
Land and improvements [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, plant and equipment	122	119	'
Construction in progress [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, plant and equipment	79	96	'
Computer equipment [Member]	'	'	'
Property, Plant and Equipment [Line Items]	'	'	'
Property, plant and equipment	$79	$80	'

GOODWILL_TRADEMARKS_AND_OTHER_2

GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Narrative) (Details) (USD $)	12 Months Ended			3 Months Ended				12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Mar. 31, 2014	Mar. 31, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
				Continuing Operations [Member]	Discontinued Operations [Member]	Trademarks [Member]	Trademarks [Member]	Other Intangible Assets [Member]
								Exclusive Manufacturing Agreement [Member]
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS [Abstract]	'	'	'	'	'	'	'	'
Impairment of goodwill and indefinite-lived intangible assets	$0	$0	$0	'	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'	'	'	'	'
Accumulated amortization of trademarks and other intangible assets	291	275	'	'	'	22	21	'
Accumulated amortization of fully amortized trademarks and other intangible assets	142	136	'	'	'	13	13	'
Intangible assets, gross	'	'	'	'	'	'	'	4
Useful life	'	'	'	'	'	'	'	'7 years
Renewal period	'	'	'	'	'	'	'	'3 years
Trademark impairment	4	0	'	3	1	'	'	'
Future amortization expense:	'	'	'	'	'	'	'	'
2015	9	'	'	'	'	'	'	'
2016	5	'	'	'	'	'	'	'
2017	5	'	'	'	'	'	'	'
2018	4	'	'	'	'	'	'	'
2019	$3	'	'	'	'	'	'	'

GOODWILL_TRADEMARKS_AND_OTHER_3

GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Goodwill) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Goodwill [Line Items]	'	'
Goodwill, beginning balance	$1,105	$1,112
Translation adjustments and other	-4	-7
Goodwill, ending balance	1,101	1,105
Cleaning [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill, beginning balance	323	323
Translation adjustments and other	0	0
Goodwill, ending balance	323	323
Lifestyle [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill, beginning balance	244	244
Translation adjustments and other	0	0
Goodwill, ending balance	244	244
Household [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill, beginning balance	85	85
Translation adjustments and other	0	0
Goodwill, ending balance	85	85
International [Member]	'	'
Goodwill [Line Items]	'	'
Goodwill, beginning balance	453	460
Translation adjustments and other	-4	-7
Goodwill, ending balance	$449	$453

GOODWILL_TRADEMARKS_AND_OTHER_4

GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS (Schedule of Intangible Assets, Excluding Goodwill) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
GOODWILL, TRADEMARKS AND OTHER INTANGIBLE ASSETS [Abstract]	'	'
Trademarks, net, beginning balance	$553	$556
Amortization	-1	-3
Impairment	-4	0
Translation adjustments and other	-1	0
Trademarks, net, ending balance	547	553
Trademarks [Member]	'	'
Indefinite-lived Intangible Assets [Line Items]	'	'
Not subject to amortization, beginning balance	537	537
Translation adjustments and other	0	0
Impairment	-4	0
Not subject to amortization, ending balance	533	537
Trademarks [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Subject to amortization, beginning balance	16	19
Amortization	-1	-3
Impairment	0	0
Translation adjustments and other	-1	0
Subject to amortization, ending balance	14	16
Other Intangible Assets [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Subject to amortization, beginning balance	74	86
Acquisitions and other additions	5	0
Amortization	-15	-15
Impairment	0	0
Translation adjustments and other	0	3
Subject to amortization, ending balance	64	74
Technology and Product formulae [Member] | Other Intangible Assets [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Subject to amortization, beginning balance	19	23
Acquisitions and other additions	0	0
Amortization	-9	-9
Impairment	0	0
Translation adjustments and other	0	5
Subject to amortization, ending balance	10	19
Other [Member] | Other Intangible Assets [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Subject to amortization, beginning balance	55	63
Acquisitions and other additions	5	0
Amortization	-6	-6
Impairment	0	0
Translation adjustments and other	0	-2
Subject to amortization, ending balance	$54	$55

ACCRUED_LIABILITIES_Details

ACCRUED LIABILITIES (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified
ACCRUED LIABILITIES [Abstract]	'	'
Trade and sales promotion	$113	$116
Compensation and employee benefit costs	102	152
Dividends	100	96
Interest	27	27
Insurance	18	20
Derivatives	17	3
Royalties	11	11
Other	84	65
Total	$472	$490

DEBT_Narrative_Details

DEBT (Narrative) (Details) (USD $)

12 Months Ended

12 Months Ended

1 Months Ended

In Millions, unless otherwise specified

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2012

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Nov. 30, 2011

Sep. 30, 2012

Mar. 31, 2013

Oct. 31, 2012

Interest Rate Contracts [Member]

Interest Rate Contracts [Member]

Commercial Paper [Member]

Commercial Paper [Member]

Revolving Line of Credit [Member]

Foreign and Other Credit Lines [Member]

Foreign and Other Credit Lines [Member]

Senior Unsecured Notes [Member]

New Senior Notes [Member]

Repaid Senior Notes [Member]

Repaid Senior Notes [Member]

Clorox Venezuela [Member]

Long-term and Short-term Debt [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long-term debt issuance

'

'

'

'

'

'

'

'

'

'

$300

$600

'

'

Long-term debt repayments

0

850

0

'

'

'

'

'

'

'

'

'

500

350

Fixed interest rate

'

'

'

'

'

'

'

'

'

'

3.80%

3.05%

5.00%

5.45%

Maturity date

'

'

'

'

'

'

'

'

'

'

15-Nov-21

15-Sep-22

'

'

Weighted average interest rate on short-term debt

'

'

'

'

'

0.28%

0.31%

'

'

'

'

'

'

'

Weighted average interest rate on notes and loans payable

0.97%

1.68%

0.85%

'

'

'

'

'

'

'

'

'

'

'

Weighted average interest rate on long-term debt

4.56%

4.56%

'

'

'

'

'

'

'

'

'

'

'

'

Weighted average interest rates on long-term debt, including the effect of interest rate swaps

4.56%

4.76%

5.21%

'

'

'

'

'

'

'

'

'

'

'

Notional amount

'

'

'

288

0

'

'

'

'

'

'

'

'

'

Line of credit facility, expiration date

'

'

'

'

'

'

'

1-May-17

'

'

'

'

'

'

Line of credit facility, borrowing capacity

1,144

1,145

'

'

'

'

'

1,100

44

7

'

'

'

'

Line of credit facility, amount outstanding

'

'

'

'

'

'

'

0

5

1

'

'

'

'

Line of credit facility, remaining borrowing capacity

'

'

'

'

'

'

'

1,100

39

'

'

'

'

'

Long-term debt maturities:

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2015

575

'

'

'

'

'

'

'

'

'

'

'

'

'

2016

300

'

'

'

'

'

'

'

'

'

'

'

'

'

2017

0

'

'

'

'

'

'

'

'

'

'

'

'

'

2018

400

'

'

'

'

'

'

'

'

'

'

'

'

'

2019

0

'

'

'

'

'

'

'

'

'

'

'

'

'

Thereafter

$900

'

'

'

'

'

'

'

'

'

'

'

'

'

DEBT_Notes_and_Loans_Payable_D

DEBT (Notes and Loans Payable) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified
Short-term Debt [Line Items]	'	'
Notes and loans payable	$143	$202
Commercial Paper [Member]	'	'
Short-term Debt [Line Items]	'	'
Notes and loans payable	141	200
Foreign Borrowings [Member]	'	'
Short-term Debt [Line Items]	'	'
Notes and loans payable	$2	$2

DEBT_Longterm_Debt_Net_of_Unam

DEBT (Long-term Debt, Net of Unamortized Discounts or Premiums) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified
Debt Instrument [Line Items]	'	'
Weighted average interest rate on long-term debt	4.56%	4.56%
Long-term debt	$2,170	$2,170
Less: Current maturities of long-term debt	-575	0
Long-term debt, noncurrent	1,595	2,170
Senior Unsecured Long-Term Notes and Debentures; 5.00%, $575 Due January 2015 [Member]	'	'
Debt Instrument [Line Items]	'	'
Weighted average interest rate on long-term debt	5.00%	5.00%
Face value	575	575
Long-term debt	575	575
Senior Unsecured Long-Term Notes and Debentures; 3.55%, $300 Due November 2015 [Member]	'	'
Debt Instrument [Line Items]	'	'
Weighted average interest rate on long-term debt	3.55%	3.55%
Face value	300	300
Long-term debt	300	300
Senior Unsecured Long-Term Notes and Debentures; 5.95%, $400 Due October 2017 [Member]	'	'
Debt Instrument [Line Items]	'	'
Weighted average interest rate on long-term debt	5.95%	5.95%
Face value	400	400
Long-term debt	399	399
Senior Unsecured Long-Term Notes and Debentures; 3.80%, $300 Due November 2021 [Member]	'	'
Debt Instrument [Line Items]	'	'
Weighted average interest rate on long-term debt	3.80%	3.80%
Face value	300	300
Long-term debt	298	298
Senior Unsecured Long-Term Notes and Debentures; 3.05%, $600 due September 2022 [Member]	'	'
Debt Instrument [Line Items]	'	'
Weighted average interest rate on long-term debt	3.05%	3.05%
Face value	600	600
Long-term debt	$598	$598

DEBT_Borrowing_Capacity_Under_

DEBT (Borrowing Capacity Under Other Financing Arrangements) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified
Line of Credit Facility [Line Items]	'	'
Line of credit facility, borrowing capacity	$1,144	$1,145
Revolving Credit Facility [Member]	'	'
Line of Credit Facility [Line Items]	'	'
Line of credit facility, borrowing capacity	1,100	1,100
Foreign Credit Lines [Member]	'	'
Line of Credit Facility [Line Items]	'	'
Line of credit facility, borrowing capacity	31	32
Other Credit Lines [Member]	'	'
Line of Credit Facility [Line Items]	'	'
Line of credit facility, borrowing capacity	$13	$13

FINANCIAL_INSTRUMENTS_AND_FAIR2

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS [Abstract]	'	'
Non-qualified deferred compensation plan assets, changes in fair value of trust assets	($1)	'
Fair value of long-term debt	2,265	2,263
Derivative [Line Items]	'	'
Derivatives	17	3
Derivative instruments subject to contractually defined counterparty liability position limits	11	3
Estimated amount of the existing net loss to be reclassified into earnings in the next 12 months	8	'
Commodity Purchase Contracts [Member]	'	'
Derivative [Line Items]	'	'
Maximum contract duration	'2 years	'
Notional amount	36	51
Commodity Purchase Contracts [Member] | Jet Fuel [Member]	'	'
Derivative [Line Items]	'	'
Notional amount	19	32
Commodity Purchase Contracts [Member] | Soybean Oil [Member]	'	'
Derivative [Line Items]	'	'
Notional amount	17	19
Interest Rate Contracts [Member]	'	'
Derivative [Line Items]	'	'
Maximum contract duration	'12 months	'
Notional amount	288	0
Payment to settle interest rate forward contracts	0	4
Foreign Exchange Contracts [Member]	'	'
Derivative [Line Items]	'	'
Maximum contract duration	'20 months	'
Foreign Exchange Contracts [Member] | Canada [Member]	'	'
Derivative [Line Items]	'	'
Notional amount	54	18
Foreign Exchange Contracts [Member] | Australia [Member]	'	'
Derivative [Line Items]	'	'
Notional amount	28	22
Foreign Exchange Contracts [Member] | New Zealand [Member]	'	'
Derivative [Line Items]	'	'
Notional amount	5	4
Foreign Exchange Contracts [Member] | Economic Hedge of Foreign Exchange Risk [Member]	'	'
Derivative [Line Items]	'	'
Notional amount	$0	$0

FINANCIAL_INSTRUMENTS_AND_FAIR3

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of Financial Instruments Measured at Fair Value) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified
Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Assets	$31	$0
Liabilities	0	0
Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Assets	1	4
Liabilities	17	3
Other assets [Member] | Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Trust assets for nonqualified deferred compensation plans	31	0
Commodity purchase derivative contracts [Member] | Other Current Assets [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Derivative assets designated as hedging instruments	1	0
Commodity purchase derivative contracts [Member] | Accrued Liabilities [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Derivative liabilities designated as hedging instruments	1	3
Interest Rate Contracts [Member] | Accrued Liabilities [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Derivative liabilities designated as hedging instruments	13	0
Foreign exchange derivative contracts [Member] | Other Current Assets [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Derivative assets designated as hedging instruments	0	4
Foreign exchange derivative contracts [Member] | Accrued Liabilities [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]	'	'
Derivative liabilities designated as hedging instruments	$3	$0

FINANCIAL_INSTRUMENTS_AND_FAIR4

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Schedule of the Effects of Derivative Instruments Designated as Hedging Instruments) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Gains (losses) recognized in OCI	($14)	$1	($37)
Gains (losses) reclassified from OCI and recognized in earnings	0	-3	4
Commodity Purchase Contracts [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Gains (losses) recognized in OCI	2	-1	-1
Gains (losses) reclassified from OCI and recognized in earnings	0	0	4
Interest Rate Contracts [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Gains (losses) recognized in OCI	-13	-1	-39
Gains (losses) reclassified from OCI and recognized in earnings	-4	-3	-2
Foreign Exchange Contracts [Member]	'	'	'
Derivative Instruments, Gain (Loss) [Line Items]	'	'	'
Gains (losses) recognized in OCI	-3	3	3
Gains (losses) reclassified from OCI and recognized in earnings	$4	$0	$2

OTHER_LIABILITIES_Details

OTHER LIABILITIES (Details) (USD $)	1 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
OTHER LIABILITIES [Abstract]	'	'	'	'
Venture agreement net terminal obligation	'	$290	$284	'
Employee benefit obligations	'	289	270	'
Taxes	'	76	74	'
Other	'	113	114	'
Total	'	768	742	'
Interest in the joint venture by venture partner	'	20.00%	20.00%	'
Agreement term	'	'20 years	'	'
Venture agreement renewal option	'	'10 years	'	'
Proceeds from sale-leasebacks, net of transaction costs	108	0	135	0
Lease term	'15 years	'	'	'
Deferred gain on sale-lease back, noncurrent portion	'	$43	$47	'

OTHER_CONTINGENCIES_AND_GUARAN1

OTHER CONTINGENCIES AND GUARANTEES (Details)	1 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2008	Mar. 31, 2008	Jun. 30, 2014	Jun. 30, 2013
	USD ($)	BRL	USD ($)	USD ($)
OTHER CONTINGENCIES AND GUARANTEES [Abstract]	'	'	'	'
Liability for aggregate future remediation costs	'	'	$14	$13
Percentage of liability for aggregate remediation and associated costs, other than legal fees	'	'	24.30%	'
Remediation period	'	'	'30 years	'
Amount awarded to Petroplus	13	23	'	'
Current value of judgment	'	'	39	'
Estimated range of loss in excess of amounts accrued, minimum	'	'	0	'
Estimated range of loss in excess of amounts accrued, maximum	'	'	33	'
Letter of credit	'	'	12	'
Letter of credit, amount outstanding	'	'	$0	'

STOCKHOLDERS_EQUITY_Share_Repu

STOCKHOLDERS' EQUITY (Share Repurchase Programs) (Details) (USD $)	12 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Share Repurchase Programs [Line Items]	'	'	'
Shares repurchased	3,046	1,500	3,419
Value of shares repurchased	$260	$128	$225
Open-market program [Member]	'	'	'
Share Repurchase Programs [Line Items]	'	'	'
Authorized repurchase amount	750	'	'
Remaining authorized repurchase amount	750	'	'
Shares repurchased	0	0	2,429
Value of shares repurchased	0	0	158
Evergreen Program [Member]	'	'	'
Share Repurchase Programs [Line Items]	'	'	'
Shares repurchased	3,046	1,500	990
Value of shares repurchased	$260	$128	$67

STOCKHOLDERS_EQUITY_Common_Sto

STOCKHOLDERS' EQUITY (Common Stock Dividends) (Details) (USD $)	3 Months Ended								12 Months Ended
	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
STOCKHOLDERS' EQUITY [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Dividends declared per common share	$0.74	$0.71	$0.71	$0.71	$0.71	$0.64	$0.64	$0.64	$2.87	$2.63	$2.44
Dividends paid per common share	'	'	'	'	'	'	'	'	$2.84	$2.56	$2.40

STOCKHOLDERS_EQUITY_Schedule_o

STOCKHOLDERS' EQUITY (Schedule of Changes in Accumulated Other Comprehensive Net Losses) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'
Beginning balance, net of tax	($367)	($396)
Other comprehensive (loss) income before reclassifications	-55	20
Amounts reclassified from accumulated other comprehensive net losses	5	9
Total other comprehensive (loss) income, net of tax	-50	29
Ending balance, net of tax	-417	-367
Foreign currency translation adjustments [Member]	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'
Beginning balance, net of tax	-209	-198
Other comprehensive (loss) income before reclassifications	-37	-11
Amounts reclassified from accumulated other comprehensive net losses	0	0
Total other comprehensive (loss) income, net of tax	-37	-11
Ending balance, net of tax	-246	-209
Net unrealized (losses) gains on derivatives [Member]	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'
Beginning balance, net of tax	-30	-33
Other comprehensive (loss) income before reclassifications	-9	0
Amounts reclassified from accumulated other comprehensive net losses	0	3
Total other comprehensive (loss) income, net of tax	-9	3
Ending balance, net of tax	-39	-30
Pension and postretirement benefit adjustments [Member]	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'
Beginning balance, net of tax	-128	-165
Other comprehensive (loss) income before reclassifications	-9	31
Amounts reclassified from accumulated other comprehensive net losses	5	6
Total other comprehensive (loss) income, net of tax	-4	37
Ending balance, net of tax	($132)	($128)

NET_EARNINGS_PER_SHARE_EPS_Det

NET EARNINGS PER SHARE (EPS) (Details)	12 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
NET EARNINGS PER SHARE (EPS) [Abstract]	'	'	'
Basic	129,558	131,075	130,852
Dilutive effect of stock options and other	2,184	1,894	1,458
Diluted	131,742	132,969	132,310
Stock options excluded from calculation of diluted net EPS	0	0	1,800

STOCKBASED_COMPENSATION_PLANS_1

STOCK-BASED COMPENSATION PLANS (Narrative) (Details) (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Stock-based compensation plans, shares authorized to grant	7,000,000	'	'
Common shares available for grant	6,000,000	'	'
Stock option plan, additional shares authorized	'	3,000,000	'
Cash received from stock options exercised	$86	$121	$79
Weighted-average fair value per share of options or awards granted	$9.69	$6.96	$9.24
Intrinsic value of options exercised	42	45	29
Performance period for performance awards	'3 years	'	'
Additional compensation expense, target cap	150.00%	'	'
Deferred stock units for nonemployee directors granted	16,000	'	'
Deferred stock units for nonemployee directors reinvested dividends	7,000	'	'
Deferred stock units for nonemployee directors distributed	23,000	'	'
Deferred stock units for nonemployee directors granted weighted average fair value on grant date	$91.79	'	'
Deferred stock units for nonemployee directors reinvested weighted average fair value on grant date	$88.96	'	'
Deferred stock units for nonemployee directors distributed weighted average fair value on grant date	$66.79	'	'
Deferred stock units for nonemployee directors outstanding	233,000	'	'
Deferred stock units for nonemployee directors outstanding weighted average fair value on grant date	62.84	'	'
Stock Options [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Vesting period	'4 years	'	'
Expiration period	'10 years	'	'
Unrecognized compensation cost	17	'	'
Unrecognized compensation cost, weighted-average period for recognition	'1 year	'	'
Restricted Stock [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Unrecognized compensation cost	1	'	'
Unrecognized compensation cost, weighted-average period for recognition	'1 year	'	'
Weighted-average grant date fair value	$89.25	$72.28	$68.52
Nonvested awards outstanding	21,000	11,000	'
Weighted-average grant date fair value per share of nonvested awards	$81	$68	'
Awards vested	3,000	'	'
Fair value of shares vested	1	1	3
Performance Units [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Unrecognized compensation cost	19	'	'
Unrecognized compensation cost, weighted-average period for recognition	'1 year	'	'
Weighted-average grant date fair value	$84.45	$72.11	$68.17
Nonvested awards outstanding	1,053,000	1,116,000	'
Weighted-average grant date fair value per share of nonvested awards	$74.68	$69.01	'
Awards vested	0	'	'
Fair value of shares vested	0	14	34
Vested awards paid by the issuance of shares	13	'	'
Vested stock awards deferred	$1	'	'
Minimum [Member] | Restricted Stock [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Vesting period	'3 years	'	'
Maximum [Member] | Restricted Stock [Member]	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Vesting period	'4 years	'	'

STOCKBASED_COMPENSATION_PLANS_2

STOCK-BASED COMPENSATION PLANS (Compensation Cost and Related Income Tax Benefit) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Stock-based compensation	$36	$35	$27
Related income tax benefit	13	13	10
Cost of products sold [Member]	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Stock-based compensation	4	4	3
Selling and administrative expenses [Member]	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Stock-based compensation	29	28	22
Research and development costs [Member]	'	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'	'
Stock-based compensation	$3	$3	$2

STOCKBASED_COMPENSATION_PLANS_3

STOCK-BASED COMPENSATION PLANS (Assumptions Utilized in the Valuation in Calculating the Compensation Expense for Stock Options Granted) (Details)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
STOCK-BASED COMPENSATION PLANS [Abstract]	'	'	'
Expected life, minimum	'5 years 8 months 12 days	'5 years 8 months 12 days	'4 years 10 months 24 days
Expected life, maximum	'5 years 8 months 12 days	'5 years 8 months 12 days	'5 years 8 months 12 days
Weighted average expected life	'5 years 8 months 12 days	'5 years 8 months 12 days	'5 years 8 months 12 days
Expected volatility, minimum	18.40%	18.70%	21.90%
Expected volatility, maximum	18.50%	19.20%	25.90%
Weighted-average volatility	18.50%	19.10%	23.50%
Risk-free interest rate, minimum	1.80%	0.60%	0.90%
Risk-free interest rate, maximum	1.90%	0.80%	1.10%
Weighted-average risk-free interest rate	1.80%	0.70%	0.90%
Dividend yield, minimum	3.40%	3.20%	3.50%
Dividend yield, maximum	3.40%	3.60%	3.80%
Weighted-average dividend yield	3.40%	3.60%	3.50%

STOCKBASED_COMPENSATION_PLANS_4

STOCK-BASED COMPENSATION PLANS (Summary of Stock Option Activity) (Details) (USD $)	12 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Number of Shares	'	'
Outstanding, beginning balance	10,257	'
Granted	1,795	'
Exercised	-1,450	'
Cancelled	-234	'
Outstanding, ending balance	10,368	10,257
Options vested	5,772	'
Weighted-Average Exercise Price per Share	'	'
Outstanding, beginning balance	$65	'
Granted	$84	'
Exercised	$60	'
Cancelled	$75	'
Outstanding, ending balance	$69	$65
Options vested	$64	'
Average remaining contractual life of options outstanding	'6 years	'7 years
Average remaining contractual life of options vested	'5 years	'
Aggregate Intrinsic Value	'	'
Outstanding	$232	$184
Options vested	$159	'

STOCKBASED_COMPENSATION_PLANS_5

STOCK-BASED COMPENSATION PLANS (Summary of Restricted Stock Award Activity) (Details) (Restricted Stock [Member], USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Restricted Stock [Member]	'	'	'
Number of Shares	'	'	'
Outstanding, beginning balance	11,000	'	'
Granted	13,000	'	'
Vested	-3,000	'	'
Forfeited	0	'	'
Outstanding, ending balance	21,000	11,000	'
Weighted-Average Grant Date Fair Value	'	'	'
Outstanding, beginning balance	$68	'	'
Granted	$89.25	$72.28	$68.52
Vested	$67	'	'
Forfeited	$0	'	'
Outstanding, ending balance	$81	$68	'

STOCKBASED_COMPENSATION_PLANS_6

STOCK-BASED COMPENSATION PLANS (Summary of Performance Stock Award Activity) (Details) (Performance Units [Member], USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Performance Units [Member]	'	'	'
Number of Shares	'	'	'
Outstanding, beginning balance	1,335	'	'
Granted	347	'	'
Distributed	-35	'	'
Forfeited	-426	'	'
Outstanding, ending balance	1,221	1,335	'
Vested and deferred	168	'	'
Weighted-Average Grant Date Fair Value	'	'	'
Outstanding, beginning balance	$66	'	'
Granted	$84.45	$72.11	$68.17
Distributed	$54	'	'
Forfeited	$67	'	'
Outstanding, ending balance	$73	$66	'
Vested and deferred	$56	'	'

LEASES_AND_OTHER_COMMITMENTS_D

LEASES AND OTHER COMMITMENTS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Purchase obligations:	'	'	'
2015	$246	'	'
2016	87	'	'
2017	65	'	'
2018	51	'	'
2019	33	'	'
Thereafter	7	'	'
Operating Leased Assets [Line Items]	'	'	'
Rent expense for all operating leases	71	71	68
Future minimum rental payments:	'	'	'
2015	47	'	'
2016	45	'	'
2017	41	'	'
2018	37	'	'
2019	32	'	'
Thereafter	127	'	'
Corporate Headquarters and Primary Research and Development Facility [Member]	'	'	'
Future minimum rental payments:	'	'	'
2015	10	'	'
2016	11	'	'
2017	11	'	'
2018	11	'	'
2019	11	'	'
Thereafter	$69	'	'

OTHER_INCOME_NET_Details

OTHER INCOME, NET (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
OTHER INCOME, NET [Abstract]	'	'	'
Income from equity investees	($13)	($12)	($11)
Insurance and other settlements	-5	0	0
Interest income	-3	-3	-3
Income from transition and related services	-1	-3	-6
Amortization of trademarks and other intangible assets (Note 7)	8	9	9
Intangible asset impairment charges (Note 7)	3	0	0
Foreign exchange transaction losses, net (Note 1)	1	8	1
Low-income housing partnership gains and other, net	0	-3	-2
Total	-10	-4	-12
Investment in low-income housing partnerships	$4	$6	'

INCOME_TAXES_Narrative_Details

INCOME TAXES (Narrative) (Details) (USD $)	3 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2011	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
INCOME TAXES [Abstract]	'	'	'	'
Undistributed earning of certain foreign subsidiaries	'	$186	'	'
Federal income tax liability on unremitted earnings	'	50	'	'
Realized and recorded excess tax benefits	'	11	11	10
Open tax year	'	'2011	'	'
Net benefit of tax and interest from settlement with Canadian Revenue Agency	7	'	'	'
Accrued interest and penalties related to uncertain tax positions	'	11	8	'
Interest and penalties of income tax expense	'	3	1	-3
Potential benefits which, if recognized, would affect the effective tax rate on earnings	'	58	56	56
Potential recognition of unrecognized tax benefits	'	30	'	'
Subject to Expiration [Member]	'	'	'	'
Tax Credit and Operating Loss Carryforwards [Line Items]	'	'	'	'
Net operating loss carryforwards	'	19	'	'
Subject to Expiration [Member] | Minimum [Member]	'	'	'	'
Tax Credit and Operating Loss Carryforwards [Line Items]	'	'	'	'
Net operating loss carryforwards, expiration	'	30-Jun-16	'	'
Subject to Expiration [Member] | Maximum [Member]	'	'	'	'
Tax Credit and Operating Loss Carryforwards [Line Items]	'	'	'	'
Net operating loss carryforwards, expiration	'	30-Jun-25	'	'
Not Subject to Expiration [Member]	'	'	'	'
Tax Credit and Operating Loss Carryforwards [Line Items]	'	'	'	'
Net operating loss carryforwards	'	4	'	'
Foreign Tax Credit Carryforward [Member] | U.S. [Member]	'	'	'	'
Tax Credit and Operating Loss Carryforwards [Line Items]	'	'	'	'
Tax credit carryforwards	'	19	'	'
Foreign Tax Credit Carryforward [Member] | Foreign [Member]	'	'	'	'
Tax Credit and Operating Loss Carryforwards [Line Items]	'	'	'	'
Tax credit carryforwards	'	$14	'	'
Tax credit carryforwards, expiration	'	30-Jun-16	'	'

INCOME_TAXES_Provision_for_Inc

INCOME TAXES (Provision for Income Taxes by Tax Jurisdiction and Domestic and Foreign Earnings before Taxes) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Current	'	'	'
Federal	$247	$245	$197
State	34	23	12
Foreign	45	19	45
Total current	326	287	254
Deferred	'	'	'
Federal	-19	-1	-4
State	2	-2	1
Foreign	-4	-5	-8
Total deferred	-21	-8	-11
Total	305	279	243
Earnings from continuing operations before income taxes	'	'	'
United States	754	724	649
Foreign	130	128	129
Earnings from continuing operations before income taxes	$884	$852	$778

INCOME_TAXES_Effective_Income_

INCOME TAXES (Effective Income Tax Rate Reconciliation) (Details)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
INCOME TAXES [Abstract]	'	'	'
Statutory federal tax rate	35.00%	35.00%	35.00%
State taxes (net of federal tax benefits)	2.60%	1.70%	1.10%
Tax differential on foreign earnings	-0.30%	-2.90%	-2.00%
Domestic manufacturing deduction	-2.30%	-2.30%	-2.30%
Change in Valuation Allowance	0.60%	0.70%	0.80%
Other differences	-1.00%	0.50%	-1.30%
Effective tax rate	34.60%	32.70%	31.30%

INCOME_TAXES_Components_of_Net

INCOME TAXES (Components of Net Deferred Tax Assets) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
In Millions, unless otherwise specified
Deferred tax assets	'	'	'
Compensation and benefit programs	$171	$176	'
Basis difference related to Venture Agreement	30	30	'
Accruals and reserves	53	55	'
Inventory costs	20	20	'
Net operating loss and tax credit carryforwards	37	33	'
Other	63	51	'
Subtotal	374	365	'
Valuation allowance	-51	-36	-20
Total deferred tax assets	323	329	'
Deferred tax liabilities	'	'	'
Fixed and intangible assets	-269	-273	'
Low-income housing partnerships	-24	-23	'
Unremitted foreign earnings	-8	-18	'
Other	-26	-24	'
Total deferred tax liabilities	-327	-338	'
Net deferred tax liabilities	($4)	($9)	'

INCOME_TAXES_Valuation_Allowan

INCOME TAXES (Valuation Allowance) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified				Foreign deferred tax assets [Member]	Foreign deferred tax assets [Member]	Foreign net operating loss carryforward and other [Member]	Foreign net operating loss carryforward and other [Member]
Valuation Allowance [Line Items]	'	'	'	'	'	'	'
Valuation allowance at beginning of year	($51)	($36)	($20)	'	'	'	'
Change in valuation allowance	'	'	'	-12	-9	-3	-7
Valuation allowance at end of year	($51)	($36)	($20)	'	'	'	'

INCOME_TAXES_Unrecognized_Tax_

INCOME TAXES (Unrecognized Tax Benefits) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
INCOME TAXES [Abstract]	'	'	'
Unrecognized tax benefits - July 1	$69	$80	$97
Gross increases - tax positions in prior periods	3	3	4
Gross decreases - tax positions in prior periods	-5	-19	-17
Gross increases - current period tax positions	7	7	5
Gross decreases - current period tax positions	0	0	-1
Lapse of applicable statute of limitations	-1	-2	-2
Settlements	-2	0	-6
Unrecognized tax benefits - June 30	$71	$69	$80

EMPLOYEE_BENEFIT_PLANS_Narrati

EMPLOYEE BENEFIT PLANS (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Aggregate cost of the defined contribution plans	$43	$45	$50
Accumulated benefit obligation	563	530	561
Change in accumulated benefit obligation	31	'	'
Domestic Qualified Retirement Income Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Discretionary contributions	0	0	0
Domestic Non-Qualified Retirement Income Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Discretionary contributions	13	11	11
Foreign Retirement Income Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Discretionary contributions	2	1	1
United States Employees [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Discretionary contributions	3.00%	'	'
Aggregate cost of the defined contribution plans	38	40	46
International Employees [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Aggregate cost of the defined contribution plans	3	1	1
Retirement Income Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Recognized prior service (cost) benefit	1	'	'
Net actuarial gains (losses) as a component of net periodic benefit cost	-11	'	'
Retirement Health Care Plan [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Assumed ultimate trend	4.50%	'	'
Ultimate trend, year reached	'2028	'	'
Basis point increase	100	'	'
Hypothetical effect of basis point change on benefit obligation	0	0	1
Recognized prior service (cost) benefit	-1	'	'
Net actuarial gains (losses) as a component of net periodic benefit cost	$3	'	'
Medical [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Assumed ultimate trend	7.30%	'	'
Prescription Drugs [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Assumed ultimate trend	7.70%	'	'

EMPLOYEE_BENEFIT_PLANS_Summari

EMPLOYEE BENEFIT PLANS (Summarized Information for Defined Benefit Retirement Income and Healthcare Plans) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Change in plan assets:	'	'	'
Fair value of assets at end of year	$432	$408	'
Retirement Income [Member]	'	'	'
Change in benefit obligations:	'	'	'
Projected benefit obligation at beginning of year	612	646	'
Service cost	3	4	0
Interest cost	27	24	29
Actuarial (gain) loss	47	-27	'
Plan amendments	0	0	'
Translation and other adjustment	-6	0	'
Benefits paid	-42	-35	'
Projected benefit obligation at end of year	641	612	646
Change in plan assets:	'	'	'
Fair value of assets at beginning of year	408	394	'
Actual return on plan assets	51	37	'
Employer contributions nonqualified plans	15	12	'
Benefits paid	-42	-35	'
Fair value of assets at end of year	432	408	394
Accrued benefit cost, net funded status	-209	-204	'
Amounts recognized in the balance sheet consist of:	'	'	'
Pension benefit assets	2	0	'
Current accrued benefit liability	-14	-17	'
Non-current accrued benefit liability	-197	-187	'
Accrued benefit cost, net	-209	-204	'
Retirement Health Care [Member]	'	'	'
Change in benefit obligations:	'	'	'
Projected benefit obligation at beginning of year	51	63	'
Service cost	1	1	1
Interest cost	2	2	3
Actuarial (gain) loss	-2	-9	'
Plan amendments	-2	-5	'
Translation and other adjustment	0	0	'
Benefits paid	-1	-1	'
Projected benefit obligation at end of year	49	51	63
Change in plan assets:	'	'	'
Fair value of assets at beginning of year	0	0	'
Actual return on plan assets	0	0	'
Employer contributions nonqualified plans	1	1	'
Benefits paid	-1	-1	'
Fair value of assets at end of year	0	0	0
Accrued benefit cost, net funded status	-49	-51	'
Amounts recognized in the balance sheet consist of:	'	'	'
Pension benefit assets	0	0	'
Current accrued benefit liability	-4	-4	'
Non-current accrued benefit liability	-45	-47	'
Accrued benefit cost, net	($49)	($51)	'

EMPLOYEE_BENEFIT_PLANS_Informa

EMPLOYEE BENEFIT PLANS (Information for Retirement Income Plans with Accumulated Benefit Obligation in Excess of Plan Assets) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
In Millions, unless otherwise specified
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Accumulated benefit obligation	$563	$530	$561
Pension Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Projected benefit obligation	538	529	'
Accumulated benefit obligation	538	528	'
Fair value of plan assets	405	405	'
Other Retirement Plans [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Projected benefit obligation	78	80	'
Accumulated benefit obligation	78	80	'
Fair value of plan assets	$0	$0	'

EMPLOYEE_BENEFIT_PLANS_Compone

EMPLOYEE BENEFIT PLANS (Components of the Net Cost of Retirement Income and Health Care Plans) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Retirement Income [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Service cost	$3	$4	$0
Interest cost	27	24	29
Expected return on plan assets	-25	-29	-31
Amortization of unrecognized items	11	12	8
Total	16	11	6
Retirement Health Care [Member]	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Service cost	1	1	1
Interest cost	2	2	3
Expected return on plan assets	0	0	0
Amortization of unrecognized items	-4	-2	-3
Total	($1)	$1	$1

EMPLOYEE_BENEFIT_PLANS_Items_N

EMPLOYEE BENEFIT PLANS (Items Not Yet Recognized as a Component of Postretirement Expense) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified
Retirement Income [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Net actuarial loss (gain)	$247	$239
Prior service cost (benefit)	1	'
Net deferred income tax (assets) liabilities	-92	'
Accumulated other comprehensive loss (income)	156	'
Retirement Health Care [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Net actuarial loss (gain)	-29	-29
Prior service cost (benefit)	-9	'
Net deferred income tax (assets) liabilities	14	'
Accumulated other comprehensive loss (income)	($24)	'

EMPLOYEE_BENEFIT_PLANS_Net_Act

EMPLOYEE BENEFIT PLANS (Net Actuarial Loss (Gain) and Prior Service Cost (Benefit) Activity Recorded in Accumulated Other Comprehensive Loss (Income)) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014
Retirement Income [Member]	'
Defined Benefit Plan Disclosure [Line Items]	'
Net actuarial loss (gain) at beginning of year	$239
Amortization during the year	-11
Loss during the year	19
Net actuarial loss (gain) at end of year	247
Retirement Health Care [Member]	'
Defined Benefit Plan Disclosure [Line Items]	'
Net actuarial loss (gain) at beginning of year	-29
Amortization during the year	2
Loss during the year	-2
Net actuarial loss (gain) at end of year	($29)

EMPLOYEE_BENEFIT_PLANS_Weighte

EMPLOYEE BENEFIT PLANS (Weighted-Average Assumptions Used to Estimate the Net Periodic Pension and Other Postretirement Benefit Costs) (Details)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Retirement Income [Member]	'	'	'
Weighted-average assumptions used to estimate the actuarial present value of benefit obligations:	'	'	'
Discount rate	4.05%	4.39%	'
Rate of compensation increase	4.46%	3.44%	'
Weighted-average assumptions used to estimate the net periodic pension and other postretirement benefit costs:	'	'	'
Discount rate	4.39%	3.87%	5.31%
Rate of compensation increase	3.44%	3.71%	3.93%
Expected return on plan assets	6.61%	7.50%	8.12%
Retirement Health Care [Member]	'	'	'
Weighted-average assumptions used to estimate the actuarial present value of benefit obligations:	'	'	'
Discount rate	4.00%	4.33%	'
Weighted-average assumptions used to estimate the net periodic pension and other postretirement benefit costs:	'	'	'
Discount rate	4.33%	3.86%	5.29%

EMPLOYEE_BENEFIT_PLANS_Expecte

EMPLOYEE BENEFIT PLANS (Expected Benefit Payments) (Details) (USD $)	Jun. 30, 2014
In Millions, unless otherwise specified
Retirement Income [Member]	'
Defined Benefit Plan Disclosure [Line Items]	'
2015	$38
2016	39
2017	40
2018	41
2019	39
Fiscal years 2020 - 2024	196
Retirement Health Care [Member]	'
Defined Benefit Plan Disclosure [Line Items]	'
2015	4
2016	4
2017	3
2018	3
2019	3
Fiscal years 2020 - 2024	$13

EMPLOYEE_BENEFIT_PLANS_Target_

EMPLOYEE BENEFIT PLANS (Target Allocations and Weighted Average Asset Allocations) (Details)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Defined Benefit Plan Disclosure [Line Items]	'	'
% Target Allocation	100.00%	100.00%
% of Plan Assets	100.00%	100.00%
U.S. Equity [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
% Target Allocation	11.00%	20.00%
% of Plan Assets	11.00%	20.00%
International Equity [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
% Target Allocation	12.00%	21.00%
% of Plan Assets	12.00%	21.00%
Fixed Income [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
% Target Allocation	74.00%	54.00%
% of Plan Assets	74.00%	54.00%
Other [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
% Target Allocation	3.00%	5.00%
% of Plan Assets	3.00%	5.00%

EMPLOYEE_BENEFIT_PLANS_Assets_

EMPLOYEE BENEFIT PLANS (Assets Carried at Fair Value) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
In Millions, unless otherwise specified
Defined Benefit Plan Disclosure [Line Items]	'	'
Cash equivalents	$3	$3
Common/Collective trusts	429	405
Total assets at fair value	432	408
Level 1 [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Cash equivalents	3	3
Total assets at fair value	3	3
Level 2 [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Common/Collective trusts	429	405
Total assets at fair value	429	405
Bond Fund [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Common/Collective trusts	309	217
Bond Fund [Member] | Level 2 [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Common/Collective trusts	309	217
Real Estate Fund [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Common/Collective trusts	12	18
Real Estate Fund [Member] | Level 2 [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Common/Collective trusts	12	18
International Equity [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Common/Collective trusts	64	93
International Equity [Member] | Level 2 [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Common/Collective trusts	64	93
Domestic Equity [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Common/Collective trusts	44	77
Domestic Equity [Member] | Level 2 [Member]	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'
Common/Collective trusts	$44	$77

SEGMENT_REPORTING_Foreign_Curr

SEGMENT REPORTING (Foreign Currency Transactions and Translation) (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
In Millions, unless otherwise specified					Argentine Subsidiary [Member]	Argentine Subsidiary [Member]	Argentine Subsidiary [Member]
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'
Subsidiary net sales as a percentage of consolidated net sales	'	'	'	'	3.00%	4.00%	3.00%
Decline in value of foreign currency	'	'	'	'	34.00%	16.00%	9.00%
Exchange rate per USD	'	'	'	'	8.1	'	'
Assets	$4,258	$4,311	'	'	$105	'	'
Cash and cash equivalents	329	299	267	259	25	'	'
Net receivables	'	'	'	'	20	'	'
Inventories	386	394	'	'	15	'	'
Net property, plant and equipment	977	1,021	'	'	20	'	'
Intangible assets	'	'	'	'	$5	'	'

SEGMENT_REPORTING_Companys_Rep

SEGMENT REPORTING (Company's Reportable Segments' Net Sales) (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net sales	'	'	'	'	'	'	'	'	$5,514	$5,533	$5,379
Earnings (losses) from continuing operations before income taxes	'	'	'	'	'	'	'	'	884	852	778
(Losses) earnings from discontinued operations, net of tax	-1	-14	-3	-3	1	-2	-1	1	-21	-1	6
Income from equity investees	'	'	'	'	'	'	'	'	13	12	11
Total assets	4,258	'	'	'	4,311	'	'	'	4,258	4,311	'
Capital expenditures	'	'	'	'	'	'	'	'	137	190	189
Depreciation and amortization	'	'	'	'	'	'	'	'	177	180	177
Share-based compensation	'	'	'	'	'	'	'	'	36	35	27
Cleaning [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net sales	'	'	'	'	'	'	'	'	1,776	1,783	1,692
Earnings (losses) from continuing operations before income taxes	'	'	'	'	'	'	'	'	428	420	381
(Losses) earnings from discontinued operations, net of tax	'	'	'	'	'	'	'	'	0	0	0
Income from equity investees	'	'	'	'	'	'	'	'	0	0	0
Total assets	887	'	'	'	905	'	'	'	887	905	'
Capital expenditures	'	'	'	'	'	'	'	'	37	57	63
Depreciation and amortization	'	'	'	'	'	'	'	'	49	52	45
Share-based compensation	'	'	'	'	'	'	'	'	11	10	13
Household [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net sales	'	'	'	'	'	'	'	'	1,709	1,693	1,676
Earnings (losses) from continuing operations before income taxes	'	'	'	'	'	'	'	'	326	336	298
(Losses) earnings from discontinued operations, net of tax	'	'	'	'	'	'	'	'	0	0	0
Income from equity investees	'	'	'	'	'	'	'	'	0	0	0
Total assets	745	'	'	'	799	'	'	'	745	799	'
Capital expenditures	'	'	'	'	'	'	'	'	53	72	79
Depreciation and amortization	'	'	'	'	'	'	'	'	67	69	73
Share-based compensation	'	'	'	'	'	'	'	'	9	9	12
Lifestyle [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net sales	'	'	'	'	'	'	'	'	936	929	901
Earnings (losses) from continuing operations before income taxes	'	'	'	'	'	'	'	'	258	259	265
(Losses) earnings from discontinued operations, net of tax	'	'	'	'	'	'	'	'	0	0	0
Income from equity investees	'	'	'	'	'	'	'	'	0	0	0
Total assets	869	'	'	'	878	'	'	'	869	878	'
Capital expenditures	'	'	'	'	'	'	'	'	11	19	18
Depreciation and amortization	'	'	'	'	'	'	'	'	19	19	18
Share-based compensation	'	'	'	'	'	'	'	'	5	5	6
International [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net sales	'	'	'	'	'	'	'	'	1,093	1,128	1,110
Earnings (losses) from continuing operations before income taxes	'	'	'	'	'	'	'	'	99	95	106
(Losses) earnings from discontinued operations, net of tax	'	'	'	'	'	'	'	'	-21	-1	6
Income from equity investees	'	'	'	'	'	'	'	'	13	12	11
Total assets	1,190	'	'	'	1,202	'	'	'	1,190	1,202	'
Capital expenditures	'	'	'	'	'	'	'	'	31	24	29
Depreciation and amortization	'	'	'	'	'	'	'	'	25	26	24
Share-based compensation	'	'	'	'	'	'	'	'	1	1	1
Corporate [Member]	'	'	'	'	'	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Net sales	'	'	'	'	'	'	'	'	0	0	0
Earnings (losses) from continuing operations before income taxes	'	'	'	'	'	'	'	'	-227	-258	-272
(Losses) earnings from discontinued operations, net of tax	'	'	'	'	'	'	'	'	0	0	0
Income from equity investees	'	'	'	'	'	'	'	'	0	0	0
Total assets	567	'	'	'	527	'	'	'	567	527	'
Capital expenditures	'	'	'	'	'	'	'	'	5	18	0
Depreciation and amortization	'	'	'	'	'	'	'	'	17	14	17
Share-based compensation	'	'	'	'	'	'	'	'	$10	$10	($5)

SEGMENT_REPORTING_Net_Sales_an

SEGMENT REPORTING (Net Sales and Long-Lived Assets by Geographic Area) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Net sales	$5,514	$5,533	$5,379
Net property, plant and equipment	977	1,021	'
Unites States [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Net sales	4,466	4,448	4,316
Net property, plant and equipment	825	860	'
Foreign [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Net sales	1,048	1,085	1,063
Net property, plant and equipment	$152	$161	'

SEGMENT_REPORTING_Concentratio

SEGMENT REPORTING (Concentration Percentages) (Details) (Net sales [Member])	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Cleaning [Member] | Liquid Bleach [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	26.00%	26.00%	26.00%
Household [Member] | Trash Bags [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	36.00%	37.00%	35.00%
Household [Member] | Charcoal [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	34.00%	32.00%	35.00%
International [Member] | Liquid Bleach [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	28.00%	28.00%	27.00%
International [Member] | Trash Bags [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	8.00%	10.00%	10.00%
Customer Concentration [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	45.00%	45.00%	45.00%
Customer Concentration [Member] | Walmart Stores, Inc. [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	27.00%	27.00%	27.00%
Product Concentration [Member] | Liquid Bleach [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	13.00%	14.00%	14.00%
Product Concentration [Member] | Trash Bags [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	13.00%	13.00%	13.00%
Product Concentration [Member] | Charcoal [Member]	'	'	'
Concentration Risk [Line Items]	'	'	'
Concentration percentage	11.00%	10.00%	11.00%

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
RELATED PARTY TRANSACTIONS [Abstract]	'	'	'
Consumer products businesses percentage ownership, maximum	50.00%	'	'
Payments to related parties during the period	$57	$50	$49

UNAUDITED_QUARTERLY_DATA_Detai

UNAUDITED QUARTERLY DATA (Details) (USD $)	3 Months Ended								12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
UNAUDITED QUARTERLY DATA [Abstract]	'	'	'	'	'	'	'	'	'	'	'
Net sales	$1,497	$1,366	$1,308	$1,343	$1,525	$1,392	$1,302	$1,314	$5,514	$5,533	'
Cost of products sold	855	791	753	759	851	802	743	746	3,158	3,142	3,107
Earnings from continuing operations	171	151	118	139	182	135	124	132	579	573	535
Earnings (losses) from discontinued operations, net of tax	-1	-14	-3	-3	1	-2	-1	1	-21	-1	6
Net earnings	$170	$137	$115	$136	$183	$133	$123	$133	$558	$572	$541
Net earnings (losses) per share, basic	'	'	'	'	'	'	'	'	'	'	'
Continuing operations	$1.32	$1.16	$0.91	$1.07	$1.39	$1.02	$0.95	$1.01	$4.47	$4.37	$4.09
Discontinued operations	$0	($0.11)	($0.02)	($0.03)	$0	($0.01)	($0.01)	$0.01	($0.16)	$0	$0.05
Basic net earnings per share	$1.32	$1.05	$0.89	$1.04	$1.39	$1.01	$0.94	$1.02	$4.31	$4.37	$4.14
Net earnings (losses) per share, diluted	'	'	'	'	'	'	'	'	'	'	'
Continuing operations	$1.30	$1.14	$0.90	$1.05	$1.37	$1.01	$0.94	$1	$4.39	$4.31	$4.05
Discontinued operations	($0.01)	($0.10)	($0.03)	($0.02)	$0	($0.01)	($0.01)	$0.01	($0.16)	($0.01)	$0.04
Diluted net earnings per share	$1.29	$1.04	$0.87	$1.03	$1.37	$1	$0.93	$1.01	$4.23	$4.30	$4.09
Dividends declared per common share	$0.74	$0.71	$0.71	$0.71	$0.71	$0.64	$0.64	$0.64	$2.87	$2.63	$2.44
Market price (NYSE), high	$93.43	$92.75	$96.76	$87.60	$90.10	$88.63	$76.74	$73.65	$96.76	$90.10	'
Market price (NYSE), low	$86.56	$83.70	$80.20	$81.25	$81.12	$73.50	$71	$69.67	$80.20	$69.67	'
Market price (NYSE), year-end	$91.40	'	'	'	$83.14	'	'	'	$91.40	$83.14	'

VALUATION_AND_QUALIFYING_ACCOU1

VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
Allowance for Doubtful Accounts [Member]	'	'	'
Valuation and Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at beginning of period	($5)	($7)	($5)
Charged to costs and expenses	0	0	-3
Credited to costs and expenses	2	2	1
Credited to other accounts	0	0	0
Balance at end of period	-3	-5	-7
LIFO Allowance [Member]	'	'	'
Valuation and Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at beginning of period	-40	-37	-29
Charged to costs and expenses	0	-3	-8
Credited to costs and expenses	3	0	0
Credited to other accounts	1	0	0
Balance at end of period	-36	-40	-37
Valuation Allowance on Deferred Tax Assets [Member]	'	'	'
Valuation and Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at beginning of period	-36	-20	-14
Charged to costs and expenses	-25	-16	-6
Credited to costs and expenses	0	0	0
Credited to other accounts	10	0	0
Balance at end of period	-51	-36	-20
Allowance for Inventory Obsolescence [Member]	'	'	'
Valuation and Qualifying Accounts Disclosure [Line Items]	'	'	'
Balance at beginning of period	-11	-10	-11
Charged to costs and expenses	-13	-12	-13
Credited to costs and expenses	0	0	0
Credited to other accounts	10	11	14
Balance at end of period	($14)	($11)	($10)